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1017-218 Echocardiographic Predictors of Outcome in Children 
With Systemic Ventricular Dysfunction and Heart 
Failure
Colin Petko, LuAnn Minich, Melanie Everitt, Richard Holubkov, Robert Shaddy, Lloyd 
Tani, University of Utah, Salt Lake City, UT, Children’s Hospital of Philadelphia, 
Philadelphia, PA
Background: The pediatric carvedilol trial (PCT), a randomized, placebo-controlled 
clinical trial, investigated the role of carvedilol in children with heart failure and systemic 
ventricular dysfunction. The purposes of this ancillary study were to: 1) determine 
echocardiographic predictors of outcome, and 2) investigate differences in the 
performance of the predictors between the placebo and carvedilol groups.
Methods: All available baseline (prior to treatment with carvedilol or placebo) 
echocardiograms (PCT n=161) were reviewed and measurements were made, 
generating 3 echocardiographic parameters of ventricular function: 1) the diastolic and 
systolic sphericity index (only patients with left ventricular morphology, n=110), 2) the 
Doppler derived dP/dt (from systemic AV valve regurgitation Doppler tracings, n=70) and 
3) the myocardial performance (TEI) index (n=145). Echocardiographic parameters were 
compared to the composite measure of heart failure outcome data taken from the original 
PCT database (improved/unchanged/worsened) using a logistic regression model.
Results: A higher baseline TEI index was associated with worse outcome at 6 months 
for the total group of PCT patients (odds ratio 16.6, 95% conﬁdence interval 2.5-112.1, 
P-value 0.004) but not for carvedilol or placebo groups alone.
For a baseline TEI index a0.4, 61% of patients improved and 18% worsened. In patients 
with baseline TEI index q0.7, 35% improved, 50% worsened.
Neither baseline dP/dt nor systolic or diastolic sphericity was predictive of outcome in all 
PCT patients or in the carvedilol/placebo groups.
Conclusions: The TEI index, but not dP/dt or sphericity index, is useful for predicting 
outcome in children with systemic ventricular dysfunction and heart failure. Identifying 
this subset of patients at higher risk for poor outcome may allow closer follow-up as well 
as investigation into ways to improve their outcome.
9:30 a.m.
1017-219 Echocardiographic Predictors of Retrograde Aortic 
Arch Obstruction After Hybrid Palliation of Hypoplastic 
Left Heart Syndrome
Matthew J. Egan, John P. Cheatham, Bethany L. Hashiguchi, Sharon L. Hill, Alistair B. 
Phillips, Kim L. McBride, Mark Galantowicz, John P. Kovalchin, Nationwide Children’s 
Hospital, Columbus, OH
Background: Retrograde aortic arch obstruction (RAO) is a recognized complication after 
hybrid palliation of hypoplastic left heart syndrome (HLHS). RAO may lead to increased 
morbidity, mortality and additional interstage procedures. We retrospectively analyzed 
echocardiograms prior to hybrid palliation to evaluate for predictors of RAO.
Methods: Measurements of the aorta and arch were made on initial echocardiograms. 
Stent type, retrograde arch velocities and anatomic subtype of HLHS were noted. RAO 
was deﬁned as Doppler velocity greater than 3.5 m/s or requiring intervention for retrograde 
obstruction. Comparisons were made between patients (pts) with and without RAO.
Results: Of 80 pts who had hybrid palliation, 69 had HLHS anatomy. 11 pts were excluded 
due to inadequate follow-up, and 17 pts were included in the RAO group. There were 43 
males, mean weight 3 ± 0.6 kg, mean age at hybrid 9.6 ± 12 days.
Echocardiographic Measurement Comparisons
Diameter (mm) No RAO (N=41)
RAO 
(N=17)
P
value
Indexed
Diameter
(mm/
BSA^0.5)
No RAO 
(N=41) RAO(N=17)
P
value
Aortic Annulus 3.0±0.9 2.5±1.0 .080 6.6±2.0 5.4±2.0 .059
Aortic Root 4.7±1.4 3.7±1.3 .031 10.4±3.1 8.0±2.6 .016
Ascending Aorta 2.9±1.4 2.3±1.2 .165 6.4±3.3 5.0±2.4 .112
Proximal 
Transverse Arch 3.9±0.9 3.7±0.6 .442 8.7±1.8 8.2±1.2 .372
Distal Transverse 
Arch 4.2±0.9 4.2±0.8 .755 9.2±1.8 9.3±1.8 .934
Aortic Isthmus 4.1±1.0 3.6±0.6 .088 9.0±2.3 7.8±1.2 .045
Descending Aorta 5.9±0.7 6.3±1.0 .075 13.0±1.6 13.9±1.9 .121
Smaller indexed aortic root and isthmus diameters were associated with RAO. Logistic 
regression showed only the isthmus was associated with RAO. Retrograde arch velocity 
increased more rapidly over time in the RAO group. Stent type and anatomic HLHS 
subtype were not related to RAO.
Conclusions: Indexed isthmus and aortic root diameters are smaller in pts who develop 
RAO. Other arch measurements, stent type, and anatomic subtype of HLHS are not 
associated with RAO. Pts with RAO increase retrograde arch velocity at a faster rate over 
time. Initial echo measurements may help determine which pts will develop RAO.
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1017-216 Echocardiographic Characterization of Mechanical 
Dyssynchrony in Single Ventricle Patients Following 
Fontan Palliation
Haleh C. Heydarian, Wojciech Mazur, William M. Gottliebson, Kan N. Hor, Thomas R. 
Kimball, Erik C. Michelfelder, Cincinnati Children’s Hospital Medical Center, Cincinnati, 
OH, The Christ Hospital, Cincinnati, OH
Background: It has been estimated that 40-50% of subjects with single ventricular (SV) 
anatomy develop ventricular dysfunction following Fontan operation. Intraventricular 
contractile dyssynchrony (IVCD) contributes to heart failure in patients with biventricular 
circulations; however, data regarding IVCD in patients with SV are limited. Our purpose 
was to more deﬁnitively characterize and determine the incidence of IVCD in SV patients 
after Fontan palliation.
Methods: Prospective, case-control study of 38 subjects post-Fontan (mean age, 10.3 
+/- 6.9 years) with SV of both right ventricular and left ventricular morphology and 33 
normal controls (mean age, 9.5 +/- 7.3 years). Maximal time difference to peak strain 
was measured in the parasternal short axis (radial dyssynchrony, RdT) and apical four-
chamber (longitudinal dyssynchrony, LdT) views by 2D speckle tracking. Clinical data, 
including a 12-lead electrocardiogram and 2D estimates of ventricular ejection fraction 
(EF), were also assessed. IVCD was deﬁned as either RdT or LdT > 2.5 SD above normal 
mean values in control left ventricles.
Results: The prevalence of radial dyssynchrony in Fontan patients was 42% in 
single right ventricles (n = 17) and 33% in single left ventricles (n = 21). Longitudinal 
dyssynchrony was evident in 36% of right ventricles but only 7% of single left ventricles. 
Single ventricle subjects with systolic ventricular dysfunction (EF < 45%) demonstrated 
signiﬁcant longitudinal IVCD when compared to those with normal function (LdT 86 +/- 
49 vs 55 +/- 24 milliseconds, p = 0.03). LdT was positively related to QRS duration (r = 
0.47, p = 0.01) and inversely related to EF (r = -0.56, p = 0.002). There was no signiﬁcant 
relationship between RdT and either EF or QRS duration.
Conclusion: Following Fontan palliation, subjects with SV, particularly those with 
right ventricular morphology, demonstrate signiﬁcant mechanical dyssynchrony. LdT 
is signiﬁcantly related to ventricular dysfunction and QRS prolongation. These results 
suggest that synchrony should be routinely assessed in these patients and further studies 
may be beneﬁcial to evaluate the effects of resynchronization therapy in SV patients.
9:30 a.m.
1017-217 Steroid Administration for Patients With Coronary 
Artery Aneurysms After Kawasaki Disease May Be 
Associated With Worsened Involvement and Impaired 
Regression
Brian W. McCrindle, Cedric Manlhiot, Kyle Millar, Rae SM Yeung, The Hospital for Sick 
Children, Toronto, ON, Canada
Background: Steroid administration in Kawasaki disease (KD) is controversial, but has 
gained acceptance for those who do not respond to initial intravenous immunoglobulin 
(IVIG) based on observational studies. The use of steroids in other inﬂammatory 
conditions with vasculitis has prompted some to advocate its use in the setting of evolving 
coronary artery aneurysms, while the impact is unknown.
Methods: The clinical history of 80 patients (73% male; median age 2.2 years) seen from 
1990 to 2008 with coronary artery aneurysms after KD were reviewed, 19 (24%) of whom 
received systemic steroids in the acute phase (14 for <3 days, 5 for 4+ days). Coronary 
artery aneurysm z-scores were assessed at baseline, 2-3 months and 1 year after the 
acute phase. Linear regression models for repeated measures were used to determine 
the association between aneurysm z-score and steroid use, adjusting for patient age at 
diagnosis, gender, IVIG use, total days of fever, albumin level, haemoglobin level and 
platelet count.
Results: Median total duration of fever was 11 days (5-47) for patients not receiving 
steroids and 17 (6-38) for those who did (p=0.04), with 15% versus 67% receiving 
additional IVIG (p<0.001), respectively. There were no differences between groups in 
age, gender, albumin level, C-reactive protein, hemoglobin, platelet count or white blood 
cell count. Adjusted coronary artery aneurysm z scores at diagnosis, 2-3 months and 1 
year follow-up for aneurysms in the left anterior descending decreased (from +5.5 to +3.5 
to +1.9) in those not treated with steroids, but were higher at baseline and progressed 
for those treated with steroids (from +7.4 to +17.5 to +15.8), regardless of duration of 
steroid treatment. For aneurysms in the right coronary artery, similar ﬁndings were noted 
(from +6.0 to +4.5 to +2.1 in those without versus from +9.4 to +10.5 to +13.0 in those 
with steroids).
Conclusions: We note that the use of steroids in the acute phase of KD for patients 
with evolving aneurysms may be associated with worsening involvement and impaired 
regression after adjustment for differences. This may reﬂect adverse hemodynamics, 
cardiovascular risk factors and impaired vascular remodeling.
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1017-220 BNP Levels Predict Outcome in Pediatric Heart Failure 
Patients: Post-Hoc Analysis of the Pediatric Carvedilol Trial
Scott R. Auerbach, Marc E. Richmond, Jacqueline M. Lamour, Elizabeth D. Blume, Linda 
J. Addonizio, Robert E. Shaddy, Lynn Mahony, Elfriede Pahl, Daphne T. Hsu, Columbia 
University, Morgan Stanley Children’s Hospital of New York Presbyterian, New York, NY, 
Albert Einstein College of Medicine, Children’s Hospital at Monteﬁore, Bronx, NY
Background: The ability of serum B-type natriuretic peptide levels (BNP) to predict 
outcomes in children with heart failure (HF) has not been well demonstrated
Methods: BNP was correlated with HF class, age, sex, diagnosis, presence of a systemic 
LV (SLV), LVEDd Z-score and LVEF. Univariate ANOVA, linear regression, Kaplan-Meier 
analysis and multivariate Cox proportional hazards models were used in a post-hoc 
analysis of data from the randomized, double-blind, placebo-controlled Pediatric Carvedilol 
Trial. Freedom from a composite endpoint of HF hospitalization, death, or transplant was 
compared using the threshold BNP determined by receiver operating curve analysis.
Results: Median BNP was 110 pg/ml (range 4-2816) in 138 patients (pts). Median age 
was 3.4 yr (range 0.2-17 yr). Diagnosis was cardiomyopathy in 60% and congenital in 
40%; 73% had SLV. HF class was II in 73% and III/IV in 27%. Outcome events occurred 
in 31 pts: 25 HF hospitalizations, 2 deaths and 4 transplants. BNP levels did not differ by 
HF class, age, diagnosis, sex, or SLV or correlate with LVEDd Z-score (R=0.19) or LVEF 
(R=0.39). Mean BNP was higher in pts with an event (240 vs. 70 pg/ml; p<0.001). After 
controlling for age, sex, HF class, SLV, and diagnosis, BNP > 140 pg/ml and age > 2 yr 
were associated with worse outcome (HR 3.7, CI 1.6-8.4, p=0.002 and HR 4.4, CI 1.7-12, 
p=0.003 respectively).
Conclusion: In children with moderate symptomatic HF, BNP level > 140 pg/ml and age 
>2yr identiﬁed pts at higher risk for a HF outcome event within one year.
9:30 a.m.
1017-228 Is Quality Care Achievable for Complex Adult 
Congenital Heart Disease Patients Undergoing 
Cardiovascular Procedures and Admissions in a Free - 
Standing Children’s Hospital
Curt J. Daniels, Steve Crumb, Stephen C. Cook, Mark Galantowicz, Alistair Phillips, 
David Chan, Timothy Feltes, Lindsey Cook, Jenne Hickey, Sharon L. Hill, Ralph Holzer, 
John P. Cheatham, Nationwide Children’s Hospital, Columbus, OH, The Ohio State 
University, Columbus, OH
Background: A challenge for the U.S. healthcare system is where to treat the > 1 
million adults with congenital heart disease (ACHD): adult hospitals, which often lack 
CHD experience or, pediatric hospitals without adult services and, in many cases, must 
discharge adult patients (pts). Therefore, ACHD pts are frequently lost to care. The goal of 
our study was to determine whether complex ACHD pts receive quality care undergoing 
non-invasive, transcatheter,and surgical procedures in a free-standing children’s hospital 
with a multi-disciplinary ACHD program on-site and, to compare adult and pediatric 
outcomes. Methods: We reviewed all CHD pts q 18 yrs of age who underwent cardiac 
surgery (CS), cardiac catheterization (CC), electrophysiological procedures (EPP), 
transesophageal echocardiography (TEE), exercise testing and medical admissions 
(arrhythmias and heart failure) from 2002-2007. Procedural and hospital related morbidity 
and mortality were recorded. ANOVA and t-test compared adult with pediatric pts. Results: 
Overall, 782 pts, mean age 27 ± 7 yrs (range 18-80 yrs), underwent 1,600 procedures/
admissions. For 178 CS (98% > moderate CHD), mortality was 1.8% and complication rate 
was 7.3%. There was 0% mortality for 412 CC (65% interventional), 311 EPP, 401 TEE, 
244 exercise tests and 54 medical admissions. The major complication rate was 0.6% for 
both CC and EPP. No complications occurred for TEE and exercise tests. During 6 years 
and 1600 encounters, 4 pts required transfer to an adult institution (0.25%) and the overall 
mortality was 0.18%. Comparing pediatric and adult CHD pts undergoing CS and CC, no 
statistical differences were found in mortality or complications, p > 0.05. Conclusions:
Optimal setting to provide ACHD care remains complex. With a multi-disciplinary ACHD 
service on-site, our study is the ﬁrst to demonstrate 1) a low incidence of morbidity and 
mortality for complex ACHD pts undergoing cardiovascular procedures/admissions at a 
free-standing childrens hospital, and 2) outcomes comparable for adult and pediatric CHD 
pts. Future models incorporating ACHD programs within pediatric heart centers should be 
considered to care for this growing, unique, and complex population.
9:30 a.m.
1017-229 Cost-Effectiveness of Implantable Cardioverter-
Deﬁbrillators in Children With Dilated Cardiomyopathy
Brian D. Feingold, Gaurav Arora, Steven A. Webber, Kenneth J. Smith, Children’s 
Hospital of Pittsburgh of UPMC, Pittsburgh, PA, University of Pittsburgh School of 
Medicine, Pittsburgh, PA
Background: Implantable cardioverter-deﬁbrillators (ICDs) improve survival and have 
been shown to be cost-effective in adults with depressed left ventricular systolic function. 
Due to signiﬁcant differences in heart failure etiology, sudden death rates, and ICD 
complication risks in children, the applicability of these ﬁndings to the pediatric population 
is unclear.
Methods: We developed a Markov model of the cost, survival, and incremental cost-utility 
of prophylactic ICD implantation compared to typical management of chronic heart failure 
in children with dilated cardiomyopathy. Outpatients receiving medical management could 
remain stable, die suddenly (arrhythmic) or non-suddenly, or decompensate and require 
urgent listing for transplantation. Transplant related costs and survival were included in 
the model. Quality of life measures, cost data, and survival data were obtained from 
institutional or published sources.
Results: Total costs were $433,000 for the ICD strategy and $355,000 for typical 
management. Although quality adjusted survival was greater in the ICD group (6.78 vs. 
6.43 quality adjusted life years, QALYs), the incremental cost-utility ratio was $281,622 
per QALY saved with the ICD strategy. In sensitivity analyses, the ICD strategy cost less 
than the $100,000 per QALY benchmark for cost-effectiveness only when the annual 
probability of sudden death exceeded 13% or when strong increases in quality of life 
from the ICD, over the lifetime of the device, were assumed. Results were sensitive to 
variation of ICD-related reduction of sudden death, but did go below $100,000 per QALY. 
Additional analyses varying all model parameters simultaneously over plausible ranges 
(Monte Carlo analysis) showed that the ICD strategy was very unlikely to cost less than 
$100,000 per QALY.
Conclusions: Unlike the ﬁndings in adults, prophylactic use of an ICD in children with 
dilated cardiomyopathy and severely depressed left ventricular systolic function does not 
appear to be cost-effective. This is likely due to lower sudden death rates in children with 
heart failure secondary to dilated cardiomyopathy and to higher ICD complication rates.
9:30 a.m.
1017-230 Myocardial Fibrosis Identiﬁed by Cardiac Magnetic 
Resonance Delayed Enhancement Is Associated With 
Ventricular Dysfunction and Nonsustained Ventricular 
Tachycardia After Fontan Operation
Rahul H. Rathod, Ashwin Prakash, Andrew J. Powell, Tal Geva, Children’s Hospital 
Boston, Boston, MA
Background: Patients who have had a Fontan palliation for single ventricle heart disease 
may develop ventricular dysfunction and arrhythmias but the mechanisms and risk factors 
are poorly deﬁned. This study evaluated the relationship between myocardial ﬁbrosis 
identiﬁed by cardiac MRI (CMR) and ventricular performance and arrhythmias in patients 
late after the Fontan operation.
Methods: All patients following a Fontan operation who had a CMR study with myocardial 
delayed enhancement (MDE) from January 2002 to July 2008 were retrospectively 
identiﬁed. Univariate analysis was performed to assess the relationship between the 
presence and amount of MDE versus demographic, operative, ventricular parameters, 
and non-sustained ventricular tachycardia (NSVT). Multivariate linear regression analysis 
was used to identify independent associations with functional single ventricular ejection 
fraction (EF).
Results: Of the 85 patients included (65% male; median age at Fontan 4.5 [2.0, 11.2] 
years; mean age at CMR 23.1 ± 11.2 years), 21 (25%) had positive MDE in the ventricular 
myocardium. Demographic data, cardiac diagnosis, ventricular morphology, Fontan type, 
and surgical history were not signiﬁcantly different in patients with and without MDE. 
Patients with MDE had a lower mean EF (44% ± 15 v. 56% ± 10, p = 0.002), higher 
median end-diastolic volume (100 [82, 164] v. 83 [65, 100] ml/m2, p = 0.01), higher 
median end-systolic volume (63 [36, 99] v. 34 [26, 45] ml/m2, p = 0.001), higher median 
ventricular mass (62 [49, 92] v. 46 [38, 59] g/m2, p = 0.001), higher frequency of wall 
motion abnormalities (WMA) (52% v. 27%, p = 0.04), and higher frequency of NSVT 
(38% v. 13%, p = 0.02). Multivariate linear regression analysis demonstrated that higher 
MDE percent of total mass and older age at CMR were independently associated with 
lower EF (R2 = 0.59).
Conclusions: In patients who have undergone a Fontan operation, myocardial ﬁbrosis 
was common and associated with lower EF, higher ventricular volumes, regional WMA, 
and higher prevalence of NSVT. Further studies are warranted to examine the utility of 
MDE for risk stratiﬁcation and treatment of ventricular arrhythmia and dysfunction in 
Fontan patients.
9:30 a.m.
1017-231 Predictors for Short-Term Risk of Death or 
Transplantation in Children Admitted With Symptomatic 
Heart Failure
Manisha S. Patel, Alexandria M. Berg, Robert N. Vincent, William T. Mahle, Children’s Healthcare 
of Atlanta: Sibley Heart Center, Emory University School of Medicine, Atlanta, GA
Background: For children admitted with symptomatic heart failure (HF) the risk of 
mortality/need for transplantation (D/Tx) is high. Data from adult studies suggest serum 
measures, such as %lymphocytes (%lymph), are valuable predictors of outcomes. We 
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sought to identify risk factors for D/Tx in children admitted with HF.
Methods: Retrospective chart review of 105 children admitted to an academic center 
from 1/94-6/08 with clinical HF was undertaken. The most common etiology of CHF was 
dilated cardiomyopathy, 76/105 (72%). Echocardiographic and serum measures were 
collected from presentation. A stepwise multivariate Cox model was employed.
Results: There were 105 children with 148 HF hospitalizations; the mean age at 
admission was 5.8 yrs. The mean systemic ejection fraction (EF) was 0.24±0.11. The 
risk of D/Tx per hospitalization was 65/148 (44%). In multivariate analysis, lower %lymph, 
HCO3, and Na were associated with D/Tx (table), whereas EF and etiology of HF were 
not. In the latter era, serum BNP was also associated with D/Tx (p=.03).
Conclusion: Serum measures (%lymphs, HCO3, Na, BNP) routinely obtained at 
admission are predictive of D/Tx in children hospitalized for HF. Interestingly, as in adults, 
signiﬁcant lymphocytopenia is predictive of adverse outcomes. With these measures, 
clinicians may identify which patients admitted with HF are at risk for D/Tx and may 
beneﬁt from prompt Tx listing.
Risk factors for Death or Transplantation
Odds Ratio 95% CI P
% Lymphs 0.81 0.72 - 0.91 <.001
Na <138 mEq/L 2.23 1.02 - 5.10 .04
HCO3 0.86 0.79 - 0.95 .002
9:30 a.m.
1017-232 Risk Scoring Systems for Intravenous Immunoglobulin 
Resistance: Application to the Pediatric Heart Network 
Pulsed Steroid Kawasaki Disease Trial
Lynn A. Sleeper, L. LuAnn Minich, Brian M. McCrindle, Jennifer S. Li, Wilbert Mason, 
Steven D. Colan, Andrew M. Atz, Beth F. Printz, Annette L. Baker, Victoria L. Vetter, Jane 
W. Newburger, for the Pediatric Heart Network Investigators, New England Research 
Institutes, Watertown, MA
Background: Standard therapy for Kawasaki disease (KD) includes treatment (Rx) with 
IVIG, but up to 20% of patients (pts) have “IVIG resistance,” - prolonged or recrudescent 
fever >36 hr after initial IVIG infusion. Because such pts are at higher risk of coronary 
artery abnormalities (CAA), their prospective identiﬁcation would allow them to be 
targeted for additional anti-inﬂammatory therapies in trials.
Methods: We assessed the performance of 3 risk scoring systems for IVIG resistance 
from Asia and examined whether steroid therapy lowers the risk of CAA in pts prospectively 
classiﬁed as IVIG resistant. In a randomized trial of pulse steroids for primary Rx of KD, 99 
pts each received placebo or IV methylprednisolone; all received IVIG+aspirin.
Results: The cohort was 62% male and median age 2.9 yr, overall and within the 
steroid/placebo groups. For comparability with published cohorts, we applied the scoring 
algorithms to the placebo group (conventional therapy but no steroids); 16% were 
retreated with IVIG. The Kobayashi score was similar for IVIG resistant vs. responsive pts 
(median 3.0 vs. 2.0), yielding sensitivity=44%, speciﬁcity=74%, positive predictive value 
(PV)=22%, and negative PV=89% (high risk deﬁned as q4). The Egami and Sano scores 
performed similarly, but with slightly better speciﬁcity (85%). Our placebo group data 
indicated that male gender (88% in retreated group) was the strongest risk factor for IVIG 
resistance, but gender not part of other scoring systems. Other independent risk factors 
were neutrophils q 80%, lower albumin, and higher AST. Using all pts, we found that the 
steroid vs. placebo difference in mean 5-wk CA z score was similar (not different from 0) 
for pts classiﬁed (by any of the 3 algorithms) as high risk vs. low risk for IVIG resistance.
Conclusions: Risk scoring systems from Asia have good speciﬁcity but low sensitivity 
for predicting IVIG resistance when applied to a North American cohort. Pts prospectively 
classiﬁed as high risk for IVIG resistance using these risk scores did not beneﬁt from 
primary steroid therapy with respect to CA z scores. Accurate prospective identiﬁcation of 
North American pts at high risk for IVIG resistance remains a challenge.
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0924-3 The Effect of Pregnancy on Aortic Growth Rate in 
Women With Marfan Syndrome
Ryan T. Donnelly, Irene Kocolas, Nelangi M. Pinto, Charles King, Anji T. Yetman, 
University of Utah, Salt Lake City, UT
Background: There is a paucity of data assessing the impact of pregnancy on maternal 
and fetal outcomes in women with Marfan syndrome (MFS). The literature provides 
conﬂicting results with marked variation in the rate of adverse events. Existing studies 
are limited by lack of prospective patient enrollment and limited follow-up. We sought to 
assess the effect of pregnancy on maternal and fetal outcomes, and on aortic growth rate 
in a large cohort of women with MFS.
Methods: Data review was performed in all women diagnosed with MFS and followed 
between 1990-2008. Aortic growth rate prior to, during, and post-pregnancy was 
determined. The impact of maternal age, aortic size, parity and use of beta-blockers 
on aortic growth rate and outcome was assessed. Peri-partum and long-term adverse 
maternal events (dissection, aortic surgery) and adverse fetal events were noted and 
predictors sought using unpaired t-tests and Wilcox rank tests.
Results: There were 139 pregnancies in 55 women, with a median of 2 [1-7] pregnancies 
per woman, occurring at age 26 ± 5 years with an aortic diameter of 36.3 + 5.0 prior to 
pregnancy. Follow-up from last pregnancy was 12 ± 11 years during which 21 (39%) 
patients required aortic surgery at age 33 + 8 years. There were no peri-partum dissections, 
but 1 patient required urgent aortic surgery in the post-partum period. There were 18 1st
trimester miscarriages and 4/121 (3%) offspring born prior to 37 weeks. Complete aortic 
growth velocities available in 38 (69%) women demonstrated an increase in aortic growth 
during pregnancy from 0.03 + 0.04 mm/month at baseline to 0.41 + 0.3 mm/month; p<0.05. 
Postpartum aortic growth (0.30 + 0.5 mm/month) remained signiﬁcantly elevated from 
baseline (p<0.05) resulting in a larger initial aortic diameter for subsequent pregnancies.
Conclusion: Our data, representing the largest dataset of pregnancy in women with 
MFS in North America, demonstrates an adverse long-term effect of pregnancy on aortic 
growth. While pregnancy can be undertaken safely with aortic diameters < 45 mm, aortic 
growth rate accelerates and does not subsequently slow resulting in a 2-fold higher rate of 
aortic surgery in the long-term when compared to nulliparous historical controls.
12:30 p.m.
0924-4 Does Exercise Function Decline Over Time in Patients 
With a Fontan Circulation?
Susan M. Fernandes, Doff B. McElhinney, Paul Khairy, Dionne Graham, Michael J. 
Landzberg, Jonathan Rhodes, Children’s Hospital, Boston, MA
Background: To assess the evolution of exercise tolerance in patients with Fontan surgery. 
Methods: We performed a retrospective cohort study of patients with Fontan surgery 
who underwent cardiopulmonary exercise testing between November 2002 and July 
2008. Patients were required to have completed at least two tests separated by q6-month 
intervals, with adequate levels of effort (RER >1.05, or predicted heart rate >85%). Results: 
A total of 78 patients (55% male) had 189 cardiopulmonary exercise tests. The median age 
at initial study was 19.6 (8.8 - 51.1) yrs. The time interval since Fontan surgery was 13.3 ± 
5.7 yrs, with a mean time interval between the initial and most recent exercise test of 2.7 ± 
1.2yrs. A morphologic left ventricle was present in 63 (81%) patients. The Fontan type was: 
lateral tunnel in 54 (69%); right atrium to pulmonary artery in 15 (19%); right atrium to right 
ventricle in 3 (4%); extra-cardiac conduit in 5 (6%); other in 1 (1%). At baseline, the mean 
peak VO2 was 25 +7.0 ml/kg/min (64±15.8 %predicted). At the most recent study, the mean 
peak VO2 was 23.6± 7.3 ml/kg/min, (61.3 +14.5) %predicted. Percent predicted peak VO2 
declined slowly, with a median rate of decline of 1.01 (mean 0.4±7.4) % per year. Most of 
the decline occurred in patients <18 yrs of age, (median rate of decline 2.1; mean 1.7±7.6% 
per year). Thereafter, the rate of decline was less marked, (median rate of decline +0.13; 
mean +1.23 ±6.8 %per yr, p=0.038). Ventricular morphology, type of Fontan, and cardiac 
medications were not predictive of progressive exercise intolerance.
Conclusions: Although the exercise function of Fontan patients tends to decline during 
late adolescence, it appears to stabilize during early adulthood in patients cared for by a 
regional adult congenital heart center.
12:45 p.m.
0924-5 Prevalence of Left Ventricular Systolic Dysfunction in 
Adults With Repaired Tetralogy of Fallot
Craig S. Broberg, Michelle Z. Gurvitz, Francois-Pierre Mongeon, Stephen C. Cook, 
Michael G. Earing, Deborah Gersony, Joseph D. Kay, Paul Khairy, Michael Landzberg, 
George Lui, Michelle Nickolaus, Alexander R. Opotowsky, Anne Marie Valente, Carole 
A. Warnes, Gary Webb, Jamil Aboulhosn, Alliance for Adult Research in Congenital 
Cardiology, Portland, OR
Background: Left ventricular (LV) systolic dysfunction has been observed in patients with 
repaired tetralogy of Fallot, though actual prevalence of dysfunction and its associations 
are unknown.
Methods: Adults with repaired tetralogy of Fallot were identiﬁed from 9 congenital heart 
disease centers. Complete surgical and medical history data were obtained retrospectively. 
Using echocardiograms performed within two years, investigators subjectively ranked LV 
systolic function as normal (LV ejection fraction q55%), mildly (45-54%), moderately (35-
44%), or severely reduced (<35%). Speciﬁc parameters including diameters of the left 
ventricle and aortic root and Doppler indices were remeasured. Right ventricular function 
and valvular function were also subjectively scored (normal, mild, moderate or severe).
Results: Out of 433 patients analyzed (mean age 36.4 ± 11.4 years, range 18 - 70), LV 
systolic dysfunction was present in 96 (22%). Systolic function was mildly reduced in 63 
(14.5%), moderately reduced in 27 (6.2%), and severely reduced in 6 (1.4%). Estimated 
LVEF <55% was associated with older age (40 ± 13 vs. 36 ± 11 years, p=0.002), male 
gender (59% vs. 44%, p=0.01), pacemaker (20% vs. 10%, p=0.017), implanted deﬁbrillator 
(19% vs. 8%, p=0.003), and use of heart failure medication (p<0.001). Patients with > 4 
prior cardiac surgeries were more likely to have dysfunction (26% vs. 16%, p=0.012), 
though shunt placement, age at shunt, and age at repair were not different. Moderate/
severe RV systolic dysfunction were more prevalent in patients with LV dysfunction (26% 
vs. 7%, p=0.001), yet PR severity was not different (207 patients had moderate-severe 
PR, and 170 had prior PV replacement). Coronary artery disease, diabetes, and smoking 
did not explain the ﬁndings.
Conclusions: LV systolic dysfunction was found in 22% of a spectrum of adults with 
repaired tetralogy of Fallot seen at ACHD centers, and is associated with older age at 
repair, RV dysfunction, and >4 prior cardiac surgeries. Patients with LV systolic dysfunction 
were more likely to have a pacemaker or deﬁbrillator. Further study should focus on likely 
mechanisms and identify optimal prevention and treatment strategies.
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0924-6 Long-Term Outcomes of the Neoaorta After Arterial 
Switch Operation as Palliation for Transposition of the 
Great Arteries: The Milwaukee Experience
Jennifer G. Co, Michael G. Earing, Peter J. Bartz, Michele A. Frommelt, Peter C. 
Frommelt, Peter C. Frommelt, Michael E. Mitchell, James S. Tweddell, Medical College 
of Wisconsin, Milwaukee, WI
Background: Following the arterial switch operation (ASO) as palliation for D-Transposition 
of Great Arteries (D-TGA), late complications are common, in particular neoaortic root 
dilation and valve regurgitation. We sought to determine the prevalence of neoaortic 
dilation and valve regurgitation following ASO and identify associated risk factors.
Methods: From 1984-2007, 247 patients have undergone ASO at our institution. Of 
these patients, 124 are being actively followed in our program and represent our study 
cohort. Chart review was performed. Echocardiograms were reviewed and analyzed for 
the following time frames: 1 year, 5 year and > 10 year follow-up.
Results: Median age at ASO was 0.2 months (0.1-60 months). The median follow-up was 
7.2 years (1-23 years). At 1 year, 42% of patients had neoaortic root z-score > 2.5 (mean 
2.38). At 5 years, the number increased to 69% (mean 3.48, p < 0.002). However at > 10 
year follow-up, the number of patients with z-score >2.5 remained the same (69%, mean 
3.47). Risk factors for neoaortic root dilation included presence of VSD (p<0.0002), PA 
band (p <0.0006), and length of follow-up (p < 0.0001). The prevalence of neoaortic valve 
regurgitation did increase over time. At least moderate regurgitation was seen in 6% of 
pts at 1 year follow-up , 11% at 5 year and 19% at >10 years. Risk factors identiﬁed for 
neoaortic valve regurgitation were: neoaortic root dilation (p < 0.0001), DORV (p <0.001), 
PA band (p <0.03), arch reconstruction (p <0.0009) and length of follow-up (p < 0.0006). 
Age at ASO, history of coarctation of the aorta, LVOT obstruction were not signiﬁcant risk 
factors for neoaortic root dilation or neoaortic valve regurgitation. To date, no patient has 
required aortic root or valve replacement.
Conclusions: Following ASO, neoaortic root dilation and neoaortic valve regurgitation 
are common. Risk factors associated with neoaortic root dilation and neoaortic valve 
regurgitation are VSD, prior PA band prior, and length of follow-up. The prevalence of 
both increases over time, however, at 10 years, the prevalence of neoaortic root dilation 
remains stable. Continued surveillance of this population is required.
1:15 p.m.
0924-7 Delayed Atrioventricular Conduction Block Following 
Congenital Heart Surgery
Angela Lin, William T. Mahle, Patricio A. Frias, Peter S. Fischbach, Brian E. Kogon, 
Kirk R. Kanter, Paul M. Kirshbom, Children’s Healthcare of Atlanta, Atlanta, GA, Emory 
University School of Medicine, Atlanta, GA
Background: Patients undergoing repair of congenital cardiac defects involving closure 
of septal defects are at risk for immediate or delayed atrioventricular block (AVB). 
The incidence of delayed AVB following surgical repair of septal defects has not been 
deﬁned.
Methods: We performed a retrospective review of patients with ventricular septal defects 
(VSD), AV canal, tetralogy of Fallot (TOF), or routine double outlet right ventricle (DORV) 
repaired between 1999 and 2004. Patients with complex cardiac lesions or preoperative 
pacemakers were excluded. 952 patients were identiﬁed (198 AV canals, 23 DORV, 214 
TOF, 517 VSD). Hospital and outpatient records and our pacemaker database were 
reviewed for evidence of AVB. Incidence of delayed AV block risk was calculated based 
upon the entire patient cohort. AVB-free survival curve was based upon most recent 
documented outpatient EKG (n=765, median 4 years after surgery (0.1-9.2 years)). Data 
reported as median (range).
Results: There were 486 males and 466 females, median age was 6 months (0-452) 
and weight 5.8 kg (1.3-115.8). 24/952 (2.5%) had postoperative AVB. Of these, 14/952 
(1.5%) were transient with return of conduction 3 days (1-14) after surgery; 10/952 (1%) 
required a permanent pacemaker placed 9 days (2-20) after surgery. 22 patients were 
eliminated from further analysis (10- postoperative pacer, 10- surgical mortality, 1- pacer 
for sick sinus syndrome 8 mos post-op, 1- ICD for LQTS) leaving 930 at risk for delayed 
AVB. 3/930 (0.3%) had pacemakers placed for 2nd or 3rd degree block at 2, 8, and 16 
months post-op. 2 of these patients previously had transient postoperative block. The 
actuarial freedom from delayed pacemaker for AVB documented by EKG at 2, 4, and 6 
years was 99.6%.
Conclusions: The risk of delayed AVB is relatively low at 0.3-0.4%, with all of the patients 
in this series presenting within the ﬁrst two years of surgery. Transient postoperative AVB 
may be a marker for increased risk of delayed AVB, although our numbers are too small 
for analysis. This analysis may be of value in comparing the relative risks and beneﬁts of 
surgical versus transcatheter closure of septal defects.
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1026-216 Pulmonary Valve Replacement After Tetralogy of Fallot 
Repair: How Young Should We go?
Clifford W. Lindsey, W. James Parks, Brian Kogon, Denver Sallee, III, William T. Mahle, 
Emory University, Atlanta, GA, Sibley Heart Center Cardiology, Atlanta, GA
Background:Following tetralogy of Fallot (TOF) repair severe pulmonary regurgitation is 
known to impair right and left heart function and produce cardiac ﬁbrosis. Pulmonary valve 
replacement (PVR) has been shown to alleviate symptoms, normalize right ventricular 
(RV) volumes and improve ventricular function. To date, most studies addressing the role 
of PVR have examined older adolescents or adults. Less is known about the potential 
beneﬁts of PVR in pre-adolescents with TOF and signiﬁcant RV dilatation. Methods: 
Cardiac MRI (cMRI) is routinely employed in the assessment of school-age children 
following TOF repair at our institution. We reviewed the clinical data for all pre-adolescents 
(a13 yrs) with TOF who underwent cMRI and/or PVR. Serial cMRI data were analyzed to 
determine the change in RV end-diastolic volume (indexed to body surface area), RV and 
left ventricular (LV) ejection fractions, and pulmonary regurgitant fraction (PRF). Where 
available, cMRI data post-PVR were compared to pre-PVR data. Results: During the 
study period there were 106 pre-adolescents with TOF who had cMRI. The median age 
of complete repair was 5.1 months, range 6 days to 3.4 years. Thirty-two subjects (30%) 
had more than one cMRI study. The mean RVEDV at time of ﬁrst study was 136 ±38ml/
m2 and the mean PRF was 37±13%. For those subjects with serial studies the RVEDV 
increased 9 ml/m2/year. Forty-four subjects (42%) had impairment in ventricular systolic 
function (RVEF <45% and/or LVEF< 55%). There were 52 subjects who underwent PVR 
at a mean age of 10.5 years, range 1 to 13 yrs. There was no hospital mortality and the 
median length of stay was 4 days. For those subjects with cMRI obtained following PVR 
the RVEDV decreased from 175 to 130 ml/m2, p=.04. No patient had more than mild 
pulmonary insufﬁciency by follow-up echo. Conclusions: Signiﬁcant RV dilatation and 
impairment in ventricular function is common in pre-adolescents for transannular repair of 
TOF. cMRI should be incorporated into the routine follow-up of this population. While PVR 
can be performed safely in this population, further studies will be needed to determine 
whether a strategy of early PVR in many pre-adolescents might improve intermediate-
term outcome.
3:30 p.m.
1026-217 Role of Immunosuppression Regimen in Post-
Transplant Lymphoproliferative Disorder in Pediatric 
Heart Transplant Patients
Jeffrey D. Dayton, Marc E. Richmond, Robert G. Weintraub, Anne T. Shipp, Manuela 
Orjuela, Linda J. Addonizio, Morgan Stanley Children’s Hospital of New York-
Presbyterian, Columbia University, New York, NY, Royal Children’s Hospital, Melbourne, 
Australia
Background:To examine the impact of type of immunosuppressive therapy on risk of 
post-transplant lymphoproliferative disorder (PTLD).
Methods:All heart transplant patients followed by two children’s hospitals (1984-2008) 
were reviewed. Patients surviving longer than 2 months post-primary transplant were 
included (n=324). Mann-Whitney, Chi-square, and Cox hazard modeling were used as 
appropriate.
Results:Indications for transplant included cardiomyopathy (59%) and congenital heart 
disease (39%). PTLD developed in 39 patients (12%) at a median time of 2.8 years 
post-transplant (range 0.2-12 years). Median age at transplant for the study population 
was 10.2 years and was signiﬁcantly younger in patients who developed PTLD (3.7 vs. 
10.8 years, p=0.002). Patients with and without PTLD did not differ by sex. Except for 
3 patients, all patients were initially treated with cyclosporine (CSA) post-transplant; 
31% were changed to tacrolimus (FK) at a median of 149 days post-transplant (range 
5-5724 days). PTLD-free survival was decreased in patients receiving FK as compared 
to those receiving CSA alone (Figure 1), with a hazard ratio of 3.63 (95% CI 1.93-6.86). 
The frequency of rejection did not differ between patients with and without PTLD (0.52 vs. 
0.51 episodes per patient year, p=0.89). Overall survival was worse in PTLD patients with 
a hazard ratio of 2.45 (95% CI 1.39-4.31).
Conclusions:Pediatric heart transplant patients treated with FK have a higher risk of 
PTLD than those treated with CSA alone.
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1026-218 Exercise Capacity Is Decreased in Children With 
Chronic Right Ventricular Pacing and Congenital 
Complete Heart Block
David Axelrod, David N. Rosenthal, Clifford Chin, Derek Obayashi, Jeffrey Kazmucha, 
Debra Hanisch, Anne M. Dubin, Lucile Packard Children’s Hospital at Stanford, Palo 
Alto, CA
Background: Long-term right ventricular (RV) pacing has been associated with 
decreased exercise capacity and left ventricular (LV) function in young adults, but not 
in children. We evaluated the effects of chronic RV pacing in children with congenital 
complete atrioventricular block (CCAVB) to study their exercise capacity and LV function.
Methods: We prospectively evaluated patients with CCAVB (with structurally normal 
hearts) who had dual chamber pacing for at least 5 years. Supine bicycle ergometry and 
resting echocardiograms were performed; quality of life (QOL) was measured with the 
PedsQL 4 instrument.
Results: Ten subjects and 22 controls were matched for age, gender and body surface 
area. Subjects were asymptomatic and had been paced for 8.9 ±2.3 years. Exercise 
testing demonstrated reduced maximal (VO2 max) and submaximal (Anaerobic Threshold 
(AT), oxygen uptake efﬁciency slope (OUES)) capacity in CCAVB patients. Maximal heart 
rate was also reduced in CCAVB patients. Heart rate was not limited by upper tracking 
rate or Wenckebach phenomenon. Resting ejection fraction was normal (60% ± 8.7%). 
QOL measures were normal.
Conclusion: Compared to controls, children with chronic RV pacing due to CCAVB have 
signiﬁcant reductions in maximal and submaximal exercise capacity, accompanied by 
chronotropic insufﬁciency. The subtle sinus node dysfunction and abnormal exercise 
capacity may be related to the initial antibody-mediated insult. Prolonged RV pacing may 
be causative or contributory. 
CCAVB patients Controls p value
Age (yrs) 12.6 ± 2.3 12.4 ± 4.5 NS
Body Surface Area (m2) 1.4 ± 0.39 1.4 ± 0.24 NS
Body Mass Index (kg/m2) 20.3 ± 6.7 19.3 ± 2.7 NS
Max HR (bpm) 150 ± 16 184 ± 16 < 0.0001
AT (% VO2max) 42.9 ± 0.4 47.0 ±0.2 0.04
OUES 1215 ± 390 1802 ± 528 0.004
VO2 max (% predicted) 73 ± 13 95 ± 10 < 0.001
3:30 p.m.
1026-219 Neurodevelopmental Outcomes in Pediatric Cardiac 
Survivors of Mechanical Circulatory Support
Shaine A. Morris, Lisa M. Noll, David D. Schwartz, Joseph W. Rossano, Jack F. Price, 
David L. Morales, David P. Nelson, Timothy C. Slesnick, Baylor College of Medicine, 
Houston, TX, Texas Children’s Hospital, Houston, TX
Background: There are limited data on pediatric neurodevelopmental sequelae after 
mechanical circulatory support. We sought to examine neurodevelopmental outcomes 
of pediatric cardiac survivors supported with ventricular assist devices (VAD) and 
extracorporeal membrane oxygenation (ECMO).
Methods: Medical records of 41 consecutive survivors (42 runs) of mechanical circulatory 
support (ECMO 18, VAD 22, ECMO to VAD 2) in cardiac patients at our institution 
from 1998-2008 were reviewed. 21 survivors’ families were available for a prospective 
interview. Using gathered data, qualitative outcome scales were developed to evaluate 
motor, cognitive, feeding and psychological impairment. Early and current functional 
outcomes were assessed.
Results: 13 of the 26 survivors who underwent head imaging had radiologic evidence of 
cerebral infarct (32% of total). Risk factors for infarct included duration of support >4 days 
(p=0.02) and presence of congenital heart disease (p=0.03). No signiﬁcant difference in 
rate of infarct was noted between ECMO and VAD. 6 patients (14%) had seizures, all of 
whom were supported with ECMO (ECMO vs. VAD, p=0.01). Median follow up for families 
interviewed was 33 months. Early moderate or severe motor impairment was present in 
41% of survivors (ECMO 50%, VAD 27%, p=0.39), and cognitive impairment in 25% of 
survivors (ECMO 27%, VAD 25%, p=1.00). Percent with motor and cognitive impairment 
minimally decreased over time. 48% of survivors had early moderate or severe impairment 
in mood, anxiety, or behavior, with improvement over time in mood and anxiety, but not 
in behavioral symptoms. 90% of ECMO survivors had early moderate or severe feeding 
impairment compared to 30% of VAD survivors (p=0.02), with improvement in both groups 
over time (current ECMO 50%, VAD 10%). At recent follow up, only 8% of survivors had 
no moderate or severe neurodevelopmental impairment in any arena, although 64% did 
not have moderate or severe motor or cognitive impairment.
Conclusions: Cognitive, motor, feeding and psychological impairment are common after 
ECMO and VAD support in children with cardiac disease. Careful neurodevelopmental 
evaluation and assistance after support is warranted.
3:30 p.m.
1026-220 Coarctation of the Aorta Therapy, Balloon Versus 
Surgery Versus Stent: Acute and Intermediate Follow-
up Results From the Congenital Cardiovascular 
Interventional Study Consortium
David J. Waight, Thomas Forbes, Congenital Cardiovascular Interventional Study 
Consortium, Children’s Hospital Medical Center of Akron, Akron, OH, Wayne State 
University, Children’s Hospital of Michigan, Detroit, MI
Background: The treatment of coarctation of the aorta (COA) primarily involves surgical 
correction of the COA(Surg), balloon angioplasty(BA) and balloon angioplasty with stent 
placement (Stent). We compare the initial and one year follow-up results for each of the 
three treatments.
Methods: The data is submitted to the CCISC data base. All treatment decisions are made 
by the treating physicians. Nonneonatal patients are eligible. One year follow-up included 
upper and lower extremity blood pressures and imaging with angiography, magnetic 
resonance imaging or CT scan.
Results: The initial treatment data includes 360 patients, Surg: 45, BA: 73, Stent: 242. 
Initial success, deﬁned as a gradient <15 mmHg and/or a COA diameter/transverse aorta 
diameter ratio >0.6 was signiﬁcantly greater for Stent and no different for the Surg and BA. 
All groups had a signiﬁcant reduction in the COA gradient and increase in the diameter at 
the COA site. Left ventricular end diastolic pressure did not decrease. Initial complication 
rate: BA 10.9%, Stent 4.6%, Surg 13.3%.
One year follow-up 155 patients: BA 29, Surg 23 and Stent 103. The success at follow-up 
based on blood pressure gradient was not different. The aneurysm rate was BA 13.8%, 
Surg 0% and Stent 1.9%. Intimal tears BA 6.9%, 0% of the Stent 0%, Stent 5.8%. Normal 
Imaging studies BA 68.9%, Surg 73.9%, Stent 80.5%. Two stent fractures were noted.
Conclusions: Balloon angioplasty, surgery and stent therapy are all successful initial 
therapies for treatment of COA outside of the neonatal period. Stent therapy is initially 
more successful than balloon angioplasty or surgery and may prove to have a lower 
rate of initial complications. Intermediate follow-up at one year does not demonstrate any 
signiﬁcant differences in success or complications, but stent therapy has a lower rate of 
aneurysm formation or intimal tears than balloon angioplasty that may become signiﬁcant 
after additional patients complete the intermediate follow-up. The surgery group has a 
higher initial complication rate, but has not had any aneurysms or intimal tears reported. 
This preliminary report will be updated as patients are entered in the data base and long 
term follow-up data becomes available.
3:30 p.m.
1026-228 Effect of Cardiac Resynchronization Therapy on 
Ventricular Remodeling and Outcomes in Pediatric 
Heart Failure
Jennifer N. Avari, Charles E. Canter, Tammy M. Bowman, Kathleen S. Jay, Timothy 
Sekarski, Edward K. Rhee, Washington University School of Medicine/St. Louis 
Children’s Hosptial, St. Louis, MO
While acute improvements in ventricular ejection have been observed, little is known 
about the impact of cardiac resynchronization therapy (CRT) on ventricular remodeling or 
patient outcomes in pediatric heart failure.
From 6/03-2/07, 16 pediatric (age <18 years) heart failure patients (6 cardiomyopathy, 8 
congenital heart disease, 2 congential heart block) had a CRT device implanted following 
AHA/ACC guidelines for adults. Criteria were: 1) 2 ventricle heart with morphologic 
systemic left ventricle (LV); 2) persistent NYHA class 3-4 despite treatment with ACE 
inhibitors & beta-blockers; 3) LV ejection fraction (EF) 120ms; and 5) 1 year follow-
up. 11/16 (68.75%) patients were referred for cardiac transplant (OHT) evaluation. 
Echocardiographic & clinical data were obtained pre-CRT, post-CRT, at 6 months & 1 
year post-CRT. Response to CRT was deﬁned as a >5% increase in EF post-optimization; 
response was assessed immediately (acute response) & at 6 and 12 months post-implant 
(chronic response).
Acute and chronic responder rates were 7/16 (43.75%) with a chronic nonresponder rate 
of 9/16 (56%). Of acute responders, 4/7 (57%) converted to chronic nonresponders; 4/7 
(57%) of chronic responders were acute nonresponders. 3/7 (43%) of acute responders 
were also chronic responders. Chronic responders had signiﬁcant improvement in EF from 
baseline (mean 22.3%, p=0.019) by 6 months & sustained beneﬁt at 12 months. Signiﬁcant 
reverse remodeling was seen in LV end diastolic volume (mean Z score reduction 1.89, 
p=0.01) & LV end systolic volume (mean Z score reduction 3.9, p=0.028) by 6 months in 
chronic responders. Heart death (deﬁned as patient death or OHT) was more common in 
chronic nonresponders (7/9) than responders (0/7) (p=0.056). Complications occurred in 
6 (37.5%) patients (2 serious events) acutely and 2 (12.5%) chronically.
CRT is a useful adjunctive, albeit not benign, therapy for pediatric heart failure patients 
which may provide an alternative to OHT. Acute response to CRT does not predict chronic 
response. In chronic responders, cardiac remodeling is seen as early as 6 months post-
implant. Patients who do not exhibit an improvement by 6 months are unlikely to beneﬁt.
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1026-229 Interstage Attrition Between the Glenn and Fontan 
Surgeries in Children With Hypoplastic Left Heart 
Syndrome
Waldemar F. Carlo, Kathleen E. Carberry, Jeffrey S. Heinle, David P. Nelson, Texas 
Children’s Hospital, Houston, TX, Baylor College of Medicine, Houston, TX
Background: With improving operative mortality for staged palliation of hypoplastic 
left heart syndrome (HLHS), interstage deaths account for an increasing proportion of 
HLHS mortality. Although causes of interstage deaths between Norwood (Stage I) and 
bidirectional Glenn (BDG, Stage II) palliation have been extensively investigated, risk 
factors for poor outcome between BDG and Fontan (Stage III) palliation have not been 
well delineated in the current era. The purpose of this study is to investigate risk factors for 
death or cardiac transplantation during the interstage period between BDG and Fontan 
procedures in children with HLHS.
Methods: Patients with HLHS who underwent BDG between August 1995 and June 2007 
were included for analysis. Preoperative patient demographics, echocardiograms, and 
cardiac catheterization data were reviewed. Interstage attrition was deﬁned as death or 
cardiac transplantation at least 30 days after BDG and before the Fontan procedure. 
Statistical analysis was carried out using Student T-test, Pearson chi square correlation, 
and Cox proportional hazard modeling for multivariable analysis.
Results: Ninety nine patients with HLHS were alive at 30 days after BDG. Of these 
patients, 11 died and 3 underwent cardiac transplantation yielding an interstage attrition 
rate of (14/99) 14%. Interstage attrition was not associated with hemodynamic data 
obtained at cardiac catheterization, aortic arch obstruction, or right ventricular dysfunction. 
Multivariable analysis demonstrated that weight Z-score at the time of BDG (hazard 
ratio 0.44, 95% conﬁdence interval 0.20-0.96, p=0.04) and the presence of moderate 
or greater atrioventricular valve regurgitation (5.5, 1.5-20.2, p=0.01) were independent 
preoperative risk factors for interstage attrition.
Conclusions: Low weight Z-score and moderate or greater atrioventricular valve 
regurgitation and are important risk factors for interstage attrition between BDG and 
Fontan procedures for children with HLHS.
3:30 p.m.
1026-230 Electrocardiographic Screening for Cardiac Disease 
Among Children With Attention Deﬁcit Disorder
William T. Mahle, Camden Hebson, Margaret J. Strieper, Children’s Healthcare of 
Atlanta, Emory University School of Medicine, Atlanta, GA
Background: Some investigators have suggested that children receiving stimulant 
medications to manage attention deﬁcit disorder (ADD) should undergo a screening 
electrocardiogram (ECG) to identify asymptomatic cardiac disease. However, no study to 
date has examined the efﬁcacy and costs of this strategy. In the present study we sought 
to determine the utility of ECG screening in children ADD.
Methods: We reviewed the clinical experience of ECG screening of subjects with ADD <21 
years of age from 4/08 to 9/08. ECGs were performed both in community medical centers 
and at a large pediatric cardiology practice; the initial interpretation was performed by a 
pediatric cardiologist. Additional cardiac care and testing which resulted from a abnormal 
initial ECG was recorded. The costs of testing were calculated based upon CPT codes 
and Medicare reimbursement rates.
Results: During the 4 month period screening ECGs were performed in 1470 children 
with ADD and were interpreted as abnormal in 119 subjects (8.1%). The most common 
abnormalities on 1st ECG were left ventricular hypertophy (22%), prolonged QT interval 
(15%) and right ventricular hypertrophy (13%). The further evaluation of these 119 
subjects included 63 transthoracic echocardiograms, 5 stress tests and 9 Holter monitor 
studies. Cardiac disease was identiﬁed in 5 subjects (0.3%), yielding a positive predictive 
value of 4.2%. Cardiac diagnoses included: Wolff-Parkinson-White syndrome (n=2), 
bicuspid aortic valve (n=2), and moderate secundum atrial septal defect (n=1). The mean 
cost of ECG screening including further testing for subjects with abnormal initial ECG 
screen was $65/child. The mean cost to identify a true positive was $22,800.
Conclusions: ECG screening for children with ADD can successfully identify cardiac 
disease in otherwise asymptomatic subjects, though the positive predictive value is <4%. 
The cost-effectiveness of this strategy depends upon the risk of adverse cardiac events-
-arrhythmias and sudden death--from stimulant medications, which at present is not 
clear. Ongoing studies are needed to know what role ECG screening should play in the 
management of children with ADD.
3:30 p.m.
1026-231 Predictors of Lower Quality of Life in Children and 
Adolescents With Surgically Palliated or Repaired 
Congenital Heart Disease: A Multicenter study
Bradley S. Marino, Kim Hart, Dennis Drotar, Ryan Tomlinson, Katelyn Mellion, Richard 
Ittenbach, Elaine Buchakjian, Lynn Mahony, Jane Newburger, Kathleen Mussatto, 
Elizabeth Tong, Mitchell I. Cohen, Anne E. Kazak, Judy A. Shea, Mark A. Helfaer, 
J. William Gaynor, Gil Wernovsky, Cincinnati Children’s Hospital Medical Center, 
Cincinnati, OH, The Children’s Hospital of Philadelphia, Philadelphia, PA
Background: Late sequelae of congenital heart disease (CHD) therapy impacts 
patient quality of life (QOL). The Pediatric Cardiac Quality of Life Inventory (PCQLI) 
is a self-administered, valid, disease-speciﬁc QOL tool with parent proxy reporting, 
that discriminates between CHD subgroups. The purpose of this study was to identify 
predictors of PCQLI Total score (QOL score) in CHD patients after surgery.
Methods: Seven US centers recruited CHD patients, age 8-18 yrs, with at least 1 prior cardiac 
surgical procedure. We obtained demographic [race, gender, income, socio-economic 
status (SES)] and medical/surgical data [number of prior surgeries/catheterizations/
hospitalizations/doctor visits, speciﬁc surgical procedure, time since last hospitalization] 
from the parent and medical record. Patient-parent pairs completed age-appropriate PCQLI 
forms (Child, age 8-12 yrs; Adolescent, age 13-18 yrs). Candidate predictor variables of 
QOL score were identiﬁed by univariate analyses with linear regression and the Wilcoxon 
Rank Sum test, and used to develop multivariable regression models.
Results: We analyzed 1518 subjects (759 patient-parent pairs); 56% of the patients were 
8-12 yrs. The median number of prior surgeries was 2 [1-10]. In multivariable modeling, 
independent factors associated with lower QOL score included lower income (7%, 
<$25,000; p<0.03), lower SES (72.7%, non-professional; p=0.005), Fontan palliation 
(24%, p< 0.04), more recent hospitalization [5.4 yrs (0.1-18 yrs); p<0.02], and a greater 
number of doctor visits in the past year [3 (0-50); p<0.01]. Lower QOL scores in the 
Child age group were associated with African American race (8%; p<0.001), genetic 
abnormality (6%; p=0.001), non-thoracic surgery (11%; p=0.04), and sternotomy (90%; 
p=0.03). In both parent groups, a mental health problem predicted lower QOL score (6%; 
p<0.001).
Conclusions: Factors associated with lower QOL score after CHD surgery include more 
recent hospitalization and a greater number of doctor visits in the past year, as well as 
non-modiﬁable factors such as Fontan palliation and lower income/SES. Studies are 
needed to identify modiﬁable factors that impact QOL in this high risk population.
3:30 p.m.
1026-232 Sudden Death After Pediatric Heart Transplantation: 
Analysis of Data From the Pediatric Heart Transplant 
Study (PHTS)
Christopher Almond, Sujata Chakravarti, Susan Myers, Margaret Foushee, Shay Dillis, 
Elfriede Pahl, Kenneth Schowengerdt, Juan Carlos Alejos, David Naftel, Children’s 
Hospital Boston, Boston, MA, University of Alabama, Birmingham, AL
Background: Sudden death is a well-recognized complication of heart transplantation. 
However, little is known about the incidence and risk factors for SD following transplant 
especially in children. The purpose of this study was to determine the incidence and risk 
factors for SD in hopes of identifying speciﬁc high-risk populations that may beneﬁt from 
primary prevention efforts.
Methods: Multi-center cohort study using the Pediatric Heart Transplant Study Group 
database; an event driven registry of children <18 years of age undergoing heart 
transplantation between 1993 and 2008. Parametric hazard analysis was used to identify 
multivariate risk factors associated with SD after heart transplant.
Results: Of 2484 children who underwent heart transplantation, 601 died of which 94 
(15.6%) were categorized as SD. Probability of freedom from SD was 97% at 1 year, 
95% at 5 years and 93% at 10 years. The median age at sudden death was 6.1 years 
(IQR 12.7), 47 (50%) were female, 28 (30%) were black, 51 (54%) had congenital heard 
disease (CHD), 4/43 (9%) had coronary artery disease, and 41 (44%) had 2 or more 
episodes of rejection. Multivariate risk factors associated with SD include age greater 
than 1 year at time of transplantation, black race, and two more rejections episodes during 
the ﬁrst year.
Conclusion: Sudden death after pediatric heart transplantation is not an uncommon event. 
Age greater than 1 year at time of transplantation, black race, and recurrent rejection within 
the ﬁrst year were associated with SD. Patients with one or more of these risk factors should 
be considered at risk for SD and may beneﬁt from primary prevention efforts.
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1035-216 Impact of Prenatal Diagnosis and Risk Factors for 
Preoperative Death in Neonates With Single Right 
Ventricle: Screening Results From the Pediatric Heart 
Network Single Ventricle Reconstruction Trial
Andrew M. Atz, Thomas G. Travison, Ismee A. Williams, Gail D. Pearson, William T. 
Mahle, Mark S. Sklansky, Michael D. Puchalski, Joel Kirsh, Peter C. Laussen, Michelle A. 
Frommelt, Jeffrey P. Jacobs, Jeanne M. Baffa, Catherine Krawczeski, Amanda L. Cook, 
Caren Goldberg, Svetlana Khaikin, Jack Rychik, Richard G. Ohye, Medical University of 
South Carolina, Charleston, SC, for the Pediatric Heart Network Investigators
Background: Fifteen centers participated in a NHLBI Trial of Right Ventricular vs. 
Modiﬁed Blalock-Taussig Shunt in Infants with Single Ventricle Defect Undergoing Staged 
Reconstruction. We studied screening data to ﬁnd associations between prenatal diagnosis 
and various patient characteristics, and to assess risk factors for preoperative death.
Methods: All live births with single right ventricle and planned Norwood palliation were 
screened from 5/05 to 7/08. Demographic data as well as anatomic diagnosis, gestational 
age, prenatal diagnosis status, and presence of major congenital abnormalities 
(chromosomal or extracardiac disorder potentially affecting survival) were recorded, 
along with death prior to surgery.
Results: Of 906 eligible infants, 677 (75%) had a prenatal diagnosis, 7% had a major 
congenital abnormality, 60% had aortic atresia, 6% had obstructed pulmonary venous 
return, 15% were preterm (<37 weeks), and 16% were low birth weight (<2500 g). 
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Prenatal diagnosis rates varied by study site (59%-85%, p<0.0001). Major congenital 
abnormalities were less prevalent in those with a prenatal diagnosis (6% vs. 10%, 
p=0.03). There were 26 (3%) deaths prior to planned Norwood palliation; this did not 
differ by prenatal diagnosis status (p=0.49). Preterm birth (p<0.0001), LBW (p=0.0003), 
major congenital abnormalities (p<0.0001), and obstructed pulmonary venous return 
(p=0.002) were positively associated with mortality in univariate analyses. We ﬁt a 
multivariate logistic regression model including these factors, as well as gender and race, 
as predictors. In this model, preterm birth and major congenital abnormalities remained 
signiﬁcantly associated with preoperative mortality.
Conclusions: In the largest contemporary cohort of neonates with single right ventricle 
to date, preoperative death was independently associated with preterm birth and with 
major congenital abnormalities. Major congenital anomalies were less common among 
those with prenatal diagnosis. This may reﬂect differential pregnancy outcomes when 
extracardiac problems are present and may confound the lack of association between 
prenatal diagnosis and preoperative mortality.
9:30 a.m.
1035-217 Coarctation of the Aorta: Life-Long Surveillance Is 
Mandatory Following Surgical Repair
Harold M. Burkhart, Heidi Connolly, Morgan Brown, Joseph A. Dearani, Frank Cetta, 
Zhuo Li, David Majdalany, William Oliver, Carol Warnes, Hartzell V. Schaff, Mayo Clinic 
and Mayo Foundation, Rochester, MN
Background: To review the long-term outcome of patients (pt) who underwent surgical 
repair of coarctation of the aorta (CoA).
Methods: Between August 1946 and July 2005, 820 pt (70% male) with isolated CoA 
underwent primary operative repair at our center. Mean age at repair was 17 years 
(range, 2 days - 72 years). The majority (83%) had preoperative hypertension.
Results: Operations included end-to-end anastomosis in 632 pt, patch angioplasty in 73, 
interposition graft in 49, bypass graft in 30 and subclavian ﬂap or other in 36. Overall early 
mortality was 2.4%. In the last 30 years (n=225), there were no operative deaths. Mean 
follow-up was 17.4±13.8 years with a maximum of 59.3 years. Actuarial survival was 93%, 
86%, and 74% at 10, 20 and 30 years, respectively. Mean age of death was 47 years. When 
compared to an age and gender matched population, long-term survival was decreased 
(P<0.001). Older age at repair (>20 years) and preoperative hypertension were associated 
with decreased survival (P<0.001). Freedom from reintervention on the descending aorta 
was 97%, 92%, and 89% at 10, 20 and 30 years, respectively. Age of less than 1 year 
(P<0.001) and patch angioplasty (P<0.001) were independently associated with higher 
reintervention rates on the descending aorta. Pt who had initial repair before age 1, had a 
31% reintervention rate at 30 years. Freedom from any cardiac reoperation was 93%, 86%, 
and 77% at 10, 20 and 30 years, respectively. Younger age at initial repair was associated 
with the need for any cardiac reoperation (P<0.001). The majority of reoperations were for 
recoarctation, pseudoaneurysm, or aortic valve disease.
Conclusions: Primary repair of isolated CoA can be performed with low mortality. 
However, long-term survival is reduced compared to an age and gender matched 
population. In addition, there were high rates of reintervention required on the descending 
aorta decades after initial CoA repair. These ﬁndings emphasize that pt with CoA need 
life-long informed follow-up including aortic surveillance to ensure late complications are 
not missed.
9:30 a.m.
1035-218 Three-Stage Palliation of Hypoplastic Left Heart 
Syndrome in the University HealthSystem Consortium
Kimberly E. McHugh, Howard P. Gutgesell, Diane G. Hillman, University of Virginia 
Health System, Charlottesville, VA
Background: Hypoplastic left heart syndrome (HLHS) is the most serious congenital 
cardiac anomaly and is typically managed by palliative three-staged surgical repair. 
Although single-center results have been reported, there are few data regarding nation-
wide experience.
Methods: The University HealthSystem Consortium database was queried to identify 
all hospital admissions between 1998 and 2007 with a diagnosis of HLHS (ICD-9 code 
746.7). Procedure codes were used to determine surgical management and outcomes 
were ascertained by discharge status (discharged, transferred, or expired).
Results: Discharge data were present from 118 hospitals in the United States. There 
were 3,688 admissions of infants under 30 days of age. First-stage surgical palliation 
was performed in 2,174 (59%) with 29% mortality. Mortality decreased from 43% in 1998 
to 18% in 2007. Primary cardiac transplantation was performed in only 9 neonates and 
rescue transplantation in 30 with 36% mortality. A total of 274 newborns (7.4%) were 
discharged to home without surgery. Second stage palliation (age 1 month to 1 year) was 
performed in 1244 patients with 5.2% mortality and third-stage palliation (age >1 year) 
in 1084 with 4.1% mortality. An additional 45 patients over 1 year of age had cardiac 
transplantation with 16% mortality and 47 died during admissions without surgery.
Conclusions: Data from a large multicenter database indicate that in the past decade the 
majority of neonates with HLHS have been managed with three-stage surgical palliation 
with a cumulative operative mortality of 38%. Late hospital deaths and transplantations 
attest to the palliative nature of the surgical therapy.
9:30 a.m.
1035-219 Impact of Surgical Fenestration in a Cohort of Fontan 
Patients
Andrew M. Atz, Thomas G. Travison, Brian W. McCrindle, Lynn Mahony, Michael 
Quartermain, Richard V. Williams, Roger E. Breitbart, Minmin Lu, Elizabeth Radojewski, 
Renee Margossian, Wesley Covitz, Welton M. Gersony, Medical University of South 
Carolina, Charleston, SC, for the Pediatric Heart Network Investigators
Background: Creation of a systemic to pulmonary venous atrial level communication 
(fenestration) at the time of the Fontan procedure is commonly performed. The late status 
of these patients is not well described.
Methods: We compared preoperative, operative and postoperative patient characteristics 
between those with and without surgical fenestration among 546 subjects (age 6 to 18 
years, mean 11.9 years) enrolled in the Pediatric Heart Network Fontan Cross-sectional 
Study. We explored the fate of the fenestration post Fontan and the association of a 
currently patent fenestration on health status and measures of ventricular performance.
Results: Fenestration was performed at Fontan completion in 361 patients (66%) and 
frequency differed by year and center (p<0.001 for each). The fenestrated group was 
similar in age at Fontan and diagnosis but had more pre-Fontan catheter and surgical 
procedures and was more likely to have moderate or greater atrioventricular valve 
regurgitation before Fontan. (p<.001 for all). The fenestrated group had shorter length 
of hospital stay (median 11 vs. 14 days, p<.001) and fewer postoperative complications 
(p<.001) including pericardial effusion (7 vs. 21%, p<.001), and pleural effusion (21 vs. 
35%, p<.001). As assessed by core lab echocardiography 8 ±3 years after Fontan, the 
fenestration was open in 19% of subjects, closed in 64%, and indeterminate in 17% 
Among those with conﬁrmed fenestration closure, 59% were by catheter intervention, 1% 
by surgical intervention, and 40% had apparent spontaneous closure. At time of Cross-
sectional testing, subjects with a current fenestration were taking more medications 
(p=0.01) and had lower resting oxygen saturation (median 89 vs. 95%, p<.001). Functional 
health status, exercise performance, echocardiographic variables, prevalence of post 
Fontan stroke or thrombosis, and growth did not differ by current fenestration status.
Conclusions: Despite an increased prevalence of some preoperative risk factors, 
subjects with a fenestration at the time of Fontan had decreased postoperative morbidity. 
Among this non randomized cohort, there were few apparent deleterious effects of a 
persistent fenestration.
9:30 a.m.
1035-220 The Disturbing Dichotomy of Female Gender in Grown-
up Congenital Heart Disease: Higher In-hospital 
Mortality and Lower Resource Utilization
Tara Karamlou, Brian S. Diggs, Ross M. Ungerleider, Karl F. Welke, University of 
Michigan, Ann Arbor, MI, Oregon Health & Science University, Portland, OR
Background: It is unknown whether gender differences in outcome exist for grown-up 
congenital heart disease (GUCH). We determined in-hospital mortality and resource 
utilization trends for GUCH females (F) compared to GUCH males (M).
Methods: Index cardiac procedures in patients q age 18 years with 12 congenital heart 
disease diagnostic groups were identiﬁed using the Nationwide Inpatient Sample 1988-
2003. Risk-adjusted regression models for in-hospital mortality, LOS, and total hospital 
charges were constructed using quintiles of years. 
Results: N=7937 cases were identiﬁed, yielding a national estimate of 40369 ± 1343 
cases. N=22663±739 (56%) were (F) and 17669±681 (44%) were (M). (F) outnumbered 
(M) across all year quintiles, P<0.001. (F) mortality was almost double that for (M) across 
time (Figure). After risk-adjustment, female gender remained a signiﬁcant risk-factor 
for in-hospital death throughout all year-quintiles (odds ratio of 1.3). Male gender was 
associated with longer hospital LOS (P<0.001) and higher hospital charges (71 ± 13 
(X1000 dollars); P<0.001).
Conclusions: Despite an overall improvement in GUCH outcomes over time, female 
gender remains a signiﬁcant risk-factor for death. Unlike for adult acquired cardiac 
surgery, however, hospital expenditures are higher among (M) compared to (F) in the 
absence of differences in age, medical comorbidities, or diagnostic group. Further studies 
investigating potential reasons for gender differences among GUCH are needed.
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9:30 a.m.
1035-228 The Assessment of Regional Right Ventricular 
Function in Patients After Repaired Tetralogy of Fallot: 
Myocardial Strain Measurement by Speckle Tracking 
Echocardiography in Comparison With Tagging by 
Cardiac Magnetic Resonance Imaging
Erik Lyseggen, Rachel Wald, Andrew N. Redington, Candice K. Silversides, Samuel 
C. Siu, Yves Provost, Erwin N. Oechslin, Toronto Congenital Cardiac Centre for Adults, 
Toronto, ON, Canada, Rikshospitalet University Hospital, University of Oslo, Oslo, Norway
Background: Speckle tracking echocardiography (STE) is a new noninvasive method for 
angle independent assessment of regional myocardial function. This method may prove 
superior to Tissue Doppler echocardiography (TDE) particularly in pts with congenital 
heart disease. We introduce STE as a novel method for assessment of right ventricular 
(RV) free wall strain in repaired tetralogy of Fallot (TOF). We validate these results against 
RV strain as measured by cardiac magnetic resonance imaging (CMR) tagging.
Methods: We prospectively enrolled 21 consecutive pts (age 33±11 yrs) with repaired 
TOF (age at repair 8±7 yrs). Echocardiography and CMR were performed on the same 
day. RV long-axis recordings (4-ch view) were obtained by conventional 2D grayscale 
echocardiography. The following parameters were adjusted for optimal speckle quality: 
sampling rates were 81±31 frames/s, sector width was kept as narrow as possible, depth 
was adjusted to be as shallow as possible. One pt was excluded (poor image quality). 
Complete RV free wall STE datasets at base, mid and apical segments were obtained 
from 20 pts and analyzed ofﬂine with EchoPac v6.0, GE Vingmed.
CMR grid tagging images in the 4-ch view were obtained using a commercially available 
scanner, data were analyzed with Harmonic Phase Imaging (HARP v 4.0, Diagnosoft Inc).
Results: There was a good correlation (r=0.75, y=0.98x-1.4, P=0.0001) and good 
agreement (mean difference -0.89±2.5%) for average RV free wall strain analysis by 
CMR tagging and STE. Average RV free wall strain by CMR tagging was -20.7±2.9% and 
-21.23±4.0% for STE. Mean strain values by segment obtained by CMR tagging and STE 
were: (1) base -19.6±4.6% and -20.9±6.3%, (2) mid -21.4±4.3% and -22.2±5.2% and (3) 
apical -21.0±4.8% and -20.9±5.5%. At segmental levels, strain by STE was correlated 
with CMR tagging values (r=0.50, P<0.0001).
Conclusion: Regional RV free wall strain can be measured accurately by STE and is feasible 
in a bed-side clinical setting, suggesting a new echocardiographic approach for quantiﬁcation 
of regional RV systolic function in pts with repaired TOF. Average RV free wall strain correlates 
better than strain at the segmental level, when assessed by STE and CMR tagging.
9:30 a.m.
1035-229 Adults With Congenital Heart Disease: Psychological 
Needs and Treatment Preferences
Adrienne H. Kovacs, Katherine L. Bendell, Jack Colman, Jeanine L. Harrison, Erwin 
Oechslin, Candice Silversides, Toronto Congenital Cardiac Centre for Adults, Peter 
Munk Cardiac Centre, University Health Network, Toronto, ON, Canada
Background: Approximately one-third of adults with congenital heart disease (CHD) 
have mood or anxiety disorders, the majority of which go untreated. The extent to which 
this group of patients is interested in psychological services is, however, unknown. 
Patient input is important to ensure that psychological services meet patient needs and 
expectations. This study investigated the perceived psychological needs of patients and 
their treatment preferences.
Methods: Participants completed an anonymous survey that included items regarding 
current psychological needs, mental health treatment history and format preferences, 
Internet use, and interest in peer support.
Results: One-hundred and ﬁfty-ﬁve adults with CHD completed the study questionnaire 
(mean age 39 years; 50% male). Forty percent of patients (49/123) reported previous 
treatment with a psychologist, psychiatrist, or therapist/counselor. Fifty-one percent of patients 
(73/142) indicated signiﬁcant interest in at least one of seven deﬁned areas of psychological 
treatment. Patients were most interested in treatment focused on coping with heart disease 
and stress management; one-third of patients reported a high level of interest in these two 
topics. Females reported greater interest than males in treatment focused on managing 
mood and anxiety (p < 0.01), stress management (p < 0.01), and relationship difﬁculties (p 
< 0.05). Males, however, reported greater interest in treatment for substance use (p < 0.05). 
There were no signiﬁcant differences between patients with and without college or university 
degrees. There was a consistent preference for psychological treatment provided over the 
Internet and 94% of the patients had Internet access. Thirty-ﬁve percent of patients were 
interested in receiving peer support and 48% were interested in providing peer support.
Conclusions: It is not only health care providers who recognize the importance of 
psychological care for adults with CHD. As a group, patients are also very interested in 
ongoing psychological treatment and peer support. Programs are encouraged to provide 
psychological services and to maximize opportunities for interactions with other patients.
9:30 a.m.
1035-230 64 Multislice Computed Tomography Study of 
Coronaries in Adult Mustard Patients: Anatomical 
Aspects and Clinical Implications
Simona Marcora, Salvatore Giannico, Alberto Bellelli, Sthepen Sanders, Paolo Di Renzi, 
Bambino Gesu Pediatric Hospital, Rome, Italy
Background: Little is known about coronary arteries in adult patients (pts) after an atrial 
switch operation for TGA (Mustard pts) . The aim of this study was to determine coronary 
anatomy in adult Mustard pts using computed tomography (CT).
Methods: A 64-multislice CT (64-MSCT) examination, using a non-iodinated contrast agent, was 
performed in 26 Mustard pts (age 22±3 years), not suitable for MRI because of a pacemaker, for 
evaluation of ventricular function. Retrospective ECG gating was used to reconstruct MIP, MPR 
and VR images in various phases of the cardiac cycle. Two observers independently described 
the origin, epicardial course and size of the major coronary vessels .
Results: 64-MSCT identiﬁed the origin and course of the coronary arteries in all 26 pts. 
The coronary origins were usual for TGA in 17 pts (65%) and unusual in 9 pts (35%) (left 
circumﬂex coronary artery (LCx) from the right coronary artery (RCA) in 5 pts; inverted 
coronary arteries in 2 pts; and inverted RCA and LCx in 2 pts) . The RCA was dominant 
in all pts and the left coronary system was hypoplastic in most pts. LCx was moderately 
hypoplastic in 8 pts and severely hypoplastic in 9 pts (medium diameter - 1.2 mm and 0.7 mm 
respectively). A potentially dangerous coronary course was identiﬁed in 2 pts: an inter-arterial 
course of the LMCA and a LCx that coursed very close to a caval bafﬂe stent placed to treat 
caval obstruction. The diagnoses were concordant between the 2 operators for all cases.
Conclusion: 64 MSCT is an excellent non-invasive technique for studying coronary 
anatomy in adult pts after Mustard and PM. We observed a high prevalence of variant 
coronary patterns, including one associated with sudden death and one that could 
complicate an interventional procedure on the caval pathways. Finally, the left coronary 
system was hypoplastic in the majority of our Mustard pts and could cause ischemic 
injury to the left ventricle (LV) such as ﬁbrosis and myocardial dysfunction, with important 
implications for late LV retraining or biventricular resynchronization.
9:30 a.m.
1035-231 Age-Related Incidence of Asymptomatic Patent 
Foramen Ovale in 13,261 Patients Undergoing 
Cardiothoracic Surgery
Stephen A. Hart, Drew Allen, Athar Qureshi, Richard A. Krasuski, Cleveland Clinic, 
Cleveland, OH
Background: An often quoted autopsy study has suggested that the incidence of patent 
foramen ovale (PFO) decreases with age, prompting theories that PFO may close 
spontaneously or confer mortality risk. The study, however, excluded heart specimens 
with any cardiovascular disease, a population in whom discovery of PFO is common 
and leads to therapeutic dilemmas. To examine this further we studied the frequency of 
incidental PFO in a cohort of cardiothoracic surgery patients.
Methods: We reviewed the intraoperative transesophageal echocardiograms of patients 
undergoing cardiothoracic surgery between 1995 and 2006 at a large academic medical 
center. Patients with known atrial septal defects or PFO were excluded. The ﬁnal dataset 
was composed of 13,261 transesophageal echocardiograms.
Results: Incidental PFO was present in 2,291 cases (17.3%). When broken down into 5 year 
increments, the incidence was nearly constant (r-square = 0.0004, Figure). Characteristics 
including age (63.0±13.3 years), BMI (28.0±5.5 kg/m/m), history of stroke or TIA (11.4%) 
and hypertension (66.5%) were similar between those with and without PFO.
Conclusions: Incidentally discovered PFO appears to be constant with age suggesting 
that PFO does not spontaneously close late in life and may not independently confer a risk 
for mortality. Recommendations for prompt closure of all PFOs regardless of symptoms 
are currently without merit. 
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3:30 p.m.
1044-216 Impaired Pre-stenotic Aortic Elastic Properties Before 
and After Successful Endovascular Stenting of Native 
Aortic Coarctation in Adults: Too Late to Salvage?
Yat Yin Lam, Mike Mullen, Michael Y. Henein, The Chinese University of Hong Kong, 
Hong Kong, Hong Kong, Royal Brompton Hospital, London, United Kingdom
Background: Patients received apparently successful repair for coarctation of aorta had 
increased central aortic stiffness that may contribute to the observed higher cardiovascular 
mortality and morbidity. We sought to examine the effect of stenting on intermediate term 
ascending aortic elastic properties and its relation to cardiac structure and function in 
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adults with native coarctation of aorta.
Methods: We prospectively studied 20 patients (aged 30±8 years) before and at 14±2 
months following coarctation stenting at Royal Brompton Hospital from year 2001-2005. 
Aortic wall strain, distensibility and stiffness index were calculated using ascending aortic 
diameters and right arm blood pressures. Ventricular long axis function was assessed by 
pulsed-wave tissue Doppler imaging (TDI) at septal site. The results were compared with 
those of 31 normal controls.
Results: There was statistically signiﬁcant improvement in aortic obstruction (catheter-
derived gradient 32±11 vs. 10±6mmHg), LV mass index (132.8±50.1 vs. 114.7±47.7 
gram/m2), left atrial (LA) volume index (26.5±5.3 vs. 23.7±5.6 mm3/m2) and long axis 
function [TDI systolic velocity (Sa) 7.2±1.5 vs. 9.3±1.7 cm/s; TDI early diastolic velocity 
(Ea) 6.2±1.3 vs. 8.9±2.6 cm/s]. Patients still had thicker LV, larger LA and worse long axis 
function than controls after stenting. They also had impaired aortic elastic properties as 
compared to controls, which remained unchanged after stenting (aortic stiffness index 
10.7±4.5 to 10.1±3.0). Increased aortic stiffness index after stenting was moderately 
correlated with LV mass index and long axis velocities.
Conclusions: There was intermediate term improvement in cardiac structure and 
function but not ascending aortic elastic properties in adult coarctation patients following 
successful stenting, and such persistent loss of aortic compliance was related to residual 
LV hypertrophy and dysfunction. Prompt identiﬁcation of persistent aortic stiffness in 
these patients should be encouraged for rationale of treatment.
3:30 p.m.
1044-217 Nocturnal Hypoxemia in Patients With Eisenmenger 
Syndrome
Ramakrishnan S, Rajnish Juneja, Neil Bordoloi, Garima Shukla, Manvir Bhatia, Shyam 
S. Kothari, Anita Saxena, All India Institute of Medical Sciences, New Delhi, India
Purpose: leep studies have shown signiﬁcant nocturnal hypoxemia in patients with severe 
pulmonary disease and primary pulmonary hypertension. Sleep studies in Eisenmenger 
syndrome (ES) have not been reported.
Methods: Sixteen patients with ES and 8 patients with cyanotic congenital heart 
disease with decreased pulmonary blood ﬂow underwent an overnight comprehensive 
polysomnogram. The data was compared to normal age matched controls. An oxygen 
drop was deﬁned as any fall in SpO2 greater than 5% lasting for at least 9 seconds.
Results: Both the group of patients showed signiﬁcant nocturnal hypoxemia in the 
absence of apnea and hypopnea. In ES patients, an increased ODI (oxygen drop index) 
was signiﬁcantly related to lower SpO2 at baseline (p = 0.04) and after 6 min walk (p = 
0.001), sleep disturbances (p = 0.04), increase in REM sleep, and a lower DLCO value (p 
= 0.03). Patients with ODI > 10 had signiﬁcantly higher hematocrit (54 ± 3.9% Vs 47.7 ± 
3.2%, p < 0.05) than those with ODI a 10.
Conclusion: Eisenmenger syndrome patients have signiﬁcant nocturnal hypoxemia 
unrelated to hypopnea and apnea. Nocturnal desaturation occurred more frequently 
during REM sleep, and in patients with greater hematocrit. These ﬁndings may have 
important therapeutic implications.
3:30 p.m.
1044-218 Pulmonary Hypertension Compounds Hospitalization 
and Mortality in Adults With Congenital Heart Disease: 
A Population Based Study
Boris S. Lowe, Judith Therrien, Natalie Bottega, Judith Bouchardy, Liming Guo, Raluca 
Ionescu-Ittu, Louise Pilote, Giuseppe Martucci, Ariane J. Marelli, McGill Adult Unit for 
Congenital Heart Disease Excellence, McGill University Health Centre, Montreal, QC, Canada
Background: Small, pediatric and Eisenmenger cohorts have predominated previous 
studies of pulmonary hypertension (PH) associated with congenital heart disease (CHD). 
We sought to determine the prevalence of PH in a contemporary adult CHD population, 
compare mortality and hospitalization rates of patients with, and without, PH.
Methods: The source population comprised 38,430 patients aged > 18 years with CHD in 
a provincial administrative database (1983 to 2005). PH was identiﬁed by ICD-9 coding for 
primary or secondary PH. Prevalence, age, gender distributions of PH were reported in 
year 2005. We compared the annual crude rates for all-cause mortality and hospitalization 
in year 2005 of patients with, and without, PH and the corresponding age and CHD 
severity adjusted rate ratios (RR).
Results: The prevalence of PH in adult patients with CHD was 5.4% (2065 patients). The 
median age was 42 years (IQR 28 - 63 years) and 60% were female. PH increased the all-
cause mortality rate of adults with CHD more than twofold compared to patients without 
PH (adjusted RR 2.7) (ﬁgure). The crude annual hospitalization rate of CHD patients with 
vs. without PH, was 5.5 vs. 1 day per 1000 person-days (adjusted RR 4.1) (ﬁgure). PH 
complicating CHD lesions of any severity had its greatest impact on the hospitalization of 
patients aged <40 years, crude RR 5.58 (5.0 - 6.3).
Conclusions: PH is an important complication of CHD and is associated with a 
quadrupling of hospitalization and more than doubling of all-cause mortality rates. 
3:30 p.m.
1044-219 Microarray-Based High Throughput Resequencing of 
Fibrillin-1 Gene Was Useful for the Molecular Diagnosis 
of Marfan Syndrome
Naomi Ogawa, Yasushi Imai, Hiroshi Nishimura, Masayoshi Kato, Norifumi Takeda, Kan 
Nawata, Tetsuro Morota, Takahide Kohro, Jun Goto, Shinichi Takamoto, Yasunobu Hirata, 
Ryozo Nagai, Department of Cardiovascular Medicine, Graduate School of Medicine, 
the University of Tokyo, Tokyo, Japan, Department of Cardiothoracic Surgery, Graduate 
School of Medicine, the University of Tokyo, Tokyo, Japan
Background: Marfan syndrome is an autosomal dominant hereditary disorder of 
connective tissue, which sometimes causes life-threatening cardiovascular events such 
as aortic dissection and aneurysmal rupture. Presence of a mutation in ﬁbrillin -1 gene 
known to cause Marfan syndrome is one of the major criteria of Marfan syndrome. Thus, 
its accurate and fast diagnosis on the genetic basis is important in the clinical situation. 
However, direct sequencing of ﬁbrillin-1 gene is time and effort-consuming due to the 
large size of the ﬁbrillin-1 gene and the wide distribution of mutations along the entire 
length of the gene.
Methods: We designed an oligonucleotide microarray (Affymetrix) containing 13572 
25-nucleotide probes to interrogate sense and antisense sequences for 65 exons of 
ﬁbrillin-1 gene. Buffy coat DNA was isolated from 8 patients who fulﬁlled the Ghent 
criteria. The exons were ampliﬁed by polymerase chain reaction and sequenced on the 
array by hybridization. We wrote custom sequence analysis software to analyze the array 
data and all candidate mutations were validated by ﬂuorescent dideoxy DNA sequencing 
(Applied Biosystems).
Results: Among 8 patients with Marfan syndrome, 3 causative functional mutations 
(4709G>A (W1570X), 4786C>T (R1596X), 2638G>A (G880S)) were detected from 3 
patients and one of them is a novel mutation which has not been described yet to the best 
of our knowledge. In addition, two novel potentially disease-associated mutations were 
detected in the other two patients (5371T>C (C1791R), 7015T>G (C2339G)). Moreover, 
we screened some family members of the aforementioned patient with the mutation 
4786C>T (R1596X) and the same mutation was detected from one of them in a manner 
of autosomal dominant inheritance.
Conclusions: Microarray-based high throughput resequencing is a novel approach and 
provides faster and more efﬁcient method for the mutation detection in ﬁbrillin-1 gene in 
patients with Marfan syndrome. This novel genetic approach will be able to contribute to 
improvement of the diagnostic accuracy and effectiveness for Marfan syndrome.
3:30 p.m.
1044-220 The Right Ventricle Shows Distinct Wall Motion 
Characteristics in L-TGA versus D-TGA/Atrial Switch
Michelle Savacool, Philip Kilner, David Sahn, Willem A. Helbing, Harold Litt, Emanuela 
Valsangiacomo, Florence Sheehan, University of Washington, Seattle, WA
Background: Patients whose right ventricles (RV) support the systemic load may 
develop heart failure. However it is unknown whether the RV remodels similarly in different 
etiologies of systemic RV.
Method: RV wall motion and shape were measured from 3D reconstructions generated 
from magnetic resonance images in 25 patients with transposition of the great arteries 
after atrial switch (D-TGA), 17 patients with L-TGA and 9 normal subjects. Wall motion 
was measured in 11 regions of the RV free wall and septum and normalized by dividing by 
the square root of body surface area. Regional RV Shape was measured as eccentricity 
(range from 0 for a line to 1 for a circle) in 20 short-axis slices of the RV.
Results: Systemic RV patients had severe RV dilatation (end diastolic volume index 137 
± 37 vs. 84 ± 22 ml/m2 in normals, p<.001), poor RV function (ejection fraction (EF) 32 ± 
7 vs. 55 ± 5%, p<.001), and more circular cross sections (eccentricity .83 to .93 vs. below 
.66 for normals, p<.001 for all slices). L-TGA patients had better RV function than D-TGA 
patients (EF 35 ± 7 vs. 30 ± 7%, p<.05). Both groups had signiﬁcantly depressed wall 
motion in most regions compared to normal. However L-TGA had better wall motion at 
the base than D-TGA but contracted more poorly at the apex.
Conclusion: Systemic RVs are dilated, spherical, and poorly functioning. L-TGA and D-TGA 
systemic RVs have distinctive wall motion and remodeling patterns. The functional and 
morphological response to systemic pressure in the RV may differ depending on the anomaly. 
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3:30 p.m.
1044-228 The Frequency and Risk Factors for Cholelithiasis and 
Gallstones in Adult Patients With Cyanotic Congenital 
Heart Disease
Yumi Shiina, Tomohiko Toyoda, Yasutaka Kawazoe, Shigeru Tateno, Takeaki Shirai, 
Yuko Wakisaka, Kozo Matsuo, Yoshiko Mizuno, Issei Komuro, Koichiro Niwa, Chiba 
Cardiovascular Center, Ichihara, Japan
Background:Cyanotic congenital heart disease (CCHD) induces secondary 
erythrocytosis and CCHD is thought to be one of the risk factors for cholelithiasis, but 
the frequency of cholelithiasis and/or gallstones in patients with CCHD is unknown. We 
evaluated the frequency and risk factors for cholelithiasis and asymptomatic gallstones.
Methods:The incidence of cholecystectomy was reviewed from 279 registered CCHD 
patients in our center. A hundred and two patients with CHD consecutively were divided 
into 4 groups: group A 22 CCHD without reparative surgery or with palliative surgery 
(31.4±7.89 years old); group B 35 CCHD after repair who were eliminated cyanosis 
(31.4±11 years old); group C 17 acyanotic CHD without repair (44.3±16 years old); and 
group D 28 acyanotic CHD after repair (35.4±14 years old). Gallstones were studied by 
abdominal ultrasonography or CT. For analysis of risk factors, patient records regarding 
cyanotic period, family history and past abdominal surgery were reviewed and blood 
pressures, lipid proﬁles, blood sugar and liver enzyme were evaluated.
Results:Cholecystectomy due to cholelithiasis was underwent in 7 of 279 CCHD 
patients (2.5%). In group A, 7 patients (31%) underwent cholecystectomy, and 3 patients 
(18%) have gallstones. In group B, 11 patients (37%) had gallstones(p<0.05). In group 
C, nobody had gallstones, and in group D 2 patients (7%) had gallstones. SPO2 was 
signiﬁcantly lower and red blood cell, hemoglobin, hematocrit, HbA1C and total bilirubin 
levels were signiﬁcantly higher in group A (p<0.05). In group B, GTP is higher than 
those in other groups (p<0.05). In a logistic regression model for predicting gallstones 
and cholelithiasis, CCHD regardless of reparative surgery was the only signiﬁcant factor 
predicting gallstones (relative risk>19.8, 95%CI1.30-300.1).
Conclusions:The incidence of cholelithiasis and gallstones is signiﬁcantly high in CCHD 
regardless of repair. The most important factor related to gallstones was having CCHD. 
Meticulous care for detecting gallstones is necessary in CCHD patients even after 
desaturation was improved by surgical repair.
3:30 p.m.
1044-229 A Contemporary Perspective on Eisenmenger 
Syndrome in Adults: A Multicentre Study
Erwin N. Oechslin, Michael Connelly, Lise-Andree Mercier, Judith Therrien, Isabelle F. 
Vonder Muhll, Marla Kiess, Luc M. Beauchesne, Josep Rodes-Cabau, Mousa Alharbi, 
Elaine Gordon, James Tam, Bryan Dias, Gary Burggraf, Candice K. Silversides, 
Canadian Adult Congenital Heart Disease Network, Toronto, ON, Canada
Background: Eisenmenger syndrome (ES) is a systemic disease with cardiac and non-
cardiac complications. The objective was to systematically examine late complications in 
a contemporary cohort of adults with ES.
Methods: Thirteen primary adult congenital heart disease referral centers participated in 
this retrospective study. Adults (q18 yrs) with ES actively followed were included. Adverse 
events: 1) bleeding complications primarily necessitating medical consult/ intervention, 2) 
thromboembolic complications (cerebral vascular events, pulmonary thromboembolism), 
3) heart failure requiring therapy, 4) arrhythmias requiring treatment, 5) infections 
including pneumonias / cerebral abscesses. Medications speciﬁc for pulmonary arterial 
hypertension (PAH) included endothelin receptor antagonists, phosphodiesterase 
antagonists, prostacycline agonists.
Results: In total, 214 adults (69% female, mean age 42 ± 12 yrs) were included. The most 
common diagnoses were ventricular septal defects (n=89), atrioventricular septal defects 
(n=54), atrial septal defects (n=31). Eleven percent of pts were taking oral anticoagulants, 
15% were taking acetylsalicylic acid, 28% were on medical treatment speciﬁc for PAH. 
Fifty percent of pts had signiﬁcant limitations (NYHA class III/IV) and of these pts, 36% 
(39/107) were on medical therapy for PAH. The most frequent adverse events were 
related to bleeding, most commonly hemoptysis (31%, mean age at presentation 33 ± 
12 yrs). Thromboembolic events were less common (15%, mean age at presentation 31 
± 10 yrs). Heart failure developed in 20% (mean age at presentation 32 ±18 yrs) of this 
cohort and arrhythmias (SVT n=15, VT n=9, not mutually exclusive) in 10% (mean age at 
presentation 38 ±14 yrs). Pneumonia was documented in 51 pts (mean age 27 ± 17 yrs), 
cerebral abscess in 4 pts.
Conclusions: Complications occur frequently in adults with ES during their 3rd decade of life. 
Bleeding, infections and heart failure are most common adverse events. The use of medical 
therapy for pts in functional class III/IV is likely underutilized. This study highlights the need for 
continued surveillance and timely consideration of therapy speciﬁc for PAH in selected pts.
3:30 p.m.
1044-230 Quantiﬁed Diffuse Myocardial Fibrosis Is Associated 
With Myocardial Dysfunction in Congenital Heart 
Disease
Craig S. Broberg, Sumeet Chugh, Dawn Peters, Catherine Conklin, Joseph Weiss, 
George A. Pantely, David J. Sahn, Michael Jerosch-Herold, Oregon Health and Science 
University, Portland, OR
Background: The etiology of heart failure in adult congenital heart disease (ACHD) is 
poorly understood but may relate to diffuse myocardial ﬁbrosis. New magnetic resonance 
methods measuring T1 allow quantiﬁcation of extracellular volume in the myocardium.
Methods: Adults with ACHD (N=50, age 37±12 years, 60% male) prospectively underwent 
cardiac MRI (Philips 1.5 T). Signal intensity curves for blood pool and myocardium from 
a mid-ventricular plane before and after administration of gadolinium (0.15 mmol/kg) 
allowed for quantiﬁcation of a “ﬁbrosis coefﬁcient,” or the percent of extracellular space 
in the myocardium. Results were compared to normal controls (N=9) and patients with 
acquired heart failure (N=4).
Results: The ﬁbrosis coefﬁcient was abnormal in 37 (74%) patients. Mean for all ACHD 
patients (31.9±4.9%) was signiﬁcantly elevated vs. controls (25.9±3.9%, p=0.001) and 
comparable to patients with acquired heart failure (36.2±5.7%, p=0.1). The ﬁbrosis 
coefﬁcient correlated with end-diastolic volume index (R=0.56, p<0.001) and systemic 
ejection fraction (R=-0.44, p<0.001), but not with age or oxygen saturation. Values were 
highest in cyanotic patients (N=10, 34.2±1.7%, p=0.001) and patients with a systemic RV 
(N=11, 34.0±1.6%, p=0.002).
Conclusions: ACHD patients have evidence of diffuse myocardial ﬁbrosis similar to 
patients with acquired heart failure. Quantiﬁcation may facilitate studies on the mechanism 
and treatment of myocardial ﬁbrosis in this population. 
3:30 p.m.
1044-231 Cardiopulmonary Stress Echocardiography: A 
Useful Tool in Assessment of Tetralogy of Fallot With 
Transannular Patch and Obligate Pulmonary Valve 
Insufﬁciency
Devyani Chowdhury, Christina Tofani, Jennifer Ting, Nora Graber, Stephen Cyran, 
William Davidson, Penn State Milton S. Hershey Medical Center, Hershey, PA
Background: Transannular Patch (TAP) repair of Tetralogy creates obligate pulmonary 
insufﬁciency (PI) causing right ventricular (RV) dilation and RV failure. The timing of re-
intervention for Pulmonary Valve Replacement (PVR) remains controversial.
Methods: Retrospective chart review, IRB approved. Cardiopulmonary stress 
echocardiograms (CPSE) were analyzed. RV Tei index calculated on transthoracic 
echocardiograms. 218 patients with Tetralogy underwent TAP repair from February 
1974 to July 2008 at Penn State Hershey Medical Center. 47 patients underwent PVR at 
29±18yr. Time between initial repair and PVR was 20 ± 12 yrs. Group A (pre-PVR) was 
compared to Group B (post-PVR) and to Group C (patients with TAP/PI not yet needing 
PVR clinically); n = 171; at 22 ± 14 yrs.
Results: Exercise time was 9 min in Group A vs. 12 min in Group B (p<.001); VO2max
(ml/kg/min) was 23 in A and 24 in B (p=ns); O2 pulse, ml/beat, was 12 in Group B vs. 9 
in Group A, p<.001. RV augmentation during exercise (measured on a scale of 0 to -2, 
0 being normal, -2 severe RV dysfunction with exercise) was more impaired in Group A 
(-1.7) vs. Group B (- 0.9) (p<.0001); Tei index for the RV was worse in Group A (0.4) versus 
Group B (0.2), p<0.0001. There was no difference in chronotropic response between A 
and B (157 Vs 169, p=ns).
The exercise duration in 99 patients in Group C was higher (11 min) than that of patients 
in Group A (9 min; p< .0001). VO2max was 28 in Group C vs. 22 in A ( p=.007). RV 
augmentation with exercise was -0.7 in Group C Vs -2.0 in Group A,( p<.0001), indicating 
better RV contractile reserve. The % maximal predicted heart rate with stress was higher 
in C vs. A (88 versus 83%) (p=0.01); QRS duration (ms) was 136 in Group C versus 151 
in Group A (p=0.02). Tei index in Group C (n=129) was 0.2 versus 0.3 in Group A (n=30) 
(p< .0001), indicating better RV systolic function in Group C.
Conclusions: CPSE demonstrated that O2 pulse and both resting and exercise RV 
systolic function improves after PVR with preserved exercise capacity. Tetralogy/PI 
patients not yet meeting PVR criteria have better RV function and contractile reserve 
than preop PVR patients. CPSE offers a means to risk stratify Tetralogy/PI for PVR and 
demonstrate physiologic beneﬁts of surgery.
3:30 p.m.
1044-232 Pregnancy and Complications in Tetralogy of Fallot; 204 
Patients
Ali Balci, Willem Drenthen, Barbara J.M. Mulder, Jolien W. Roos-Hesselink, Adriaan 
A. Voors, Hubert W. Vliegen, Werner Budts, Arie P.J. van Dijk, Dirk J. van Veldhuisen, 
Petronella G. Pieper, University Medical Centre Groningen, Groningen, The 
Netherlands, Interuniversity Cardiology Institute of the Netherlands (ICIN), Utrecht, The 
Netherlands
Backgound: Tetralogy of Fallot (ToF) is the most prevalent cyanotic heart disease in the 
Netherlands (8%). Nowadays, the long term survival from corrected ToF is up to 95%. 
Because of the increased survival, the number of female patients with a pregnancy wish 
also increases. Hemodynamic changes during pregnancy can be an extra burden during 
pregnancy in women with corrected TvF.
Purpose: To determine prevalence of complications in pregnancy for mother and 
offspring in women with corrected tetralogy of Fallot and to identify factors which can 
predict these complications.
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Methods: Data were collected from 204 patients through interviews and review of 
medical records.
Results: In 74 women 157 pregnancies were observed, (19.1% ended in an abortion). 
Of the 204 women, 135 were childless (40% by choice, 40% lacking a partner or another 
reason, 8.1% due to infertility and 12% because of fear for complications).
We observed 123 completed pregnancies in 69 patients. In 72,3% of the pregnancies 
a complication occurred (cardiac 7,3%, obstetric 16,1%, offspring 29,7% and general 
19,3%) (Table 1). Predictors for these complications could not be found.
Conclusion: Although complications occurred in 72,3% of the patients with a corrected 
tetralogy of Fallot, most complications were well treatable. Very serious complications 
occurred in 8% of pregnancies.
No predictors were found.
Table 1. Complications in pregnancy of women with ToF. N=124 
Cardiac 7.3% Obstetric 16,1% Offspring 29.7% General 19.3%
Arrhythmia 6.5 Augmentation of labor 8.1 SGA 18.5 Anaemia 6.5
Heart 
failure 0.8 Preeclampsia 3.2
Foetal 
death 4 Fever 5.6
PIH 4.8 Neonataldeath 2.4 Palpitation 3.2
CHD 2.4 Hyperemesis 1.6
Other 2.4 Hypotension 1.6
Thromboembolia 0.8
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9:30 a.m.
1053-216 Left Ventricular Diastolic Dysfunction in Adults With 
Repaired Tetralogy of Fallot
Jamil A. Aboulhosn, Craig Broberg, François-Pierre Mongeon, Deborah Gersony, 
Gary Webb, Anne Marie Valente, Michelle Nickolaus, Alexander Opotowsky, Michael 
Landzberg, George Lui, Paul Khairy, Joseph Kay, Michael Earing, Stephen Cook, Carole 
Warnes, John S. Child, Michelle Gurvitz, David Geffen School of Medicine at UCLA, Los 
Angeles, CA, Oregon Health Sciences University, Portland, OR
Background: The prevalence of LV diastolic dysfunction (DD) is unknown in adults with 
tetralogy of Fallot (TOF).
Methods: Medical history data was obtained from adults with repaired TOF at 9 North 
American congenital heart disease centers. Echocardiograms done within 2 years of the 
index clinic visit were analyzed for mitral inﬂow and annular velocities, LV dimensions and 
ejection fraction (LVEF). Right ventricular (RV) function, valve function and presence of 
atrial enlargement were subjectively scored within preset parameters. DD was present if 
lateral mitral annulus A’>E’ and/or the E/E’ ratio was > 10.
Results: Of 445 pts analyzed, sufﬁcient Doppler data was available in 220 for DD 
evaluation. 35/233 pts (15%) had A’>E’ and 47/230 (20%) had E/E’ >10. At least one 
of these ﬁndings was present in 69 pts (30%) and both were present in 12 pts (5.4%). 
DD was associated with: Older age, later age at intracardiac repair (ICR), and more 
operations. There were no differences in pulmonary regurgitation, QRS duration, RV size 
and function. A history of ventricular tachycardia (VT) was present in 28/228 (12%), 16/69 
(23%) with DD and 12/159 (7.5%) without DD (p=0.001). Pts with DD were more likely 
to have a deﬁbrillator (ICD) (16% versus 4.6%, p<0.01). There was no difference in ACE 
inhibitor, beta-blocker, or diuretic use.
Conclusions: Doppler evidence of LVDD is present in 30% of adults with repaired TOF, 
and is associated with more surgeries and older age at ICR. Pts with DD are more likely 
to have a history of VT.
Normal Diastolic Function Diastolic Dysfunction P
Pts, n=228 (%) 159 (70%) 69 (30%)
Age (yrs) 35+/-11 41 +/- 12 <0.01
Age at ICR (yrs) 6.4 +/- 7 9.2 +/- 9 0.04
LVEF <50% 12/157 (7.6%) 11/68 (16%) 0.052
Heart Surgeries 2.3 +/- 1.7 2.8 +/- 1.8 0.04
VT 12/159 (7.5%) 16/69 (23%) <0.01
ICD 7/150 (4.6%) 11/68 (16%) 0.004
9:30 a.m.
1053-217 Marfan Syndrome Affects Arterial Stiffness and 
Endothelial Function by Modifying the Expression of 
Matrix Metalloproteinases
Stella Brilli, Dimitris Tousoulis, Charalambos Antoniades, George Hatzis, Nikos 
Ioakeimidis, Charalambos Vlachopoulos, Georgia Papazoglou, Nikos Papageorgiou, Elli 
Stefanadi, Alexios Antonopoulos, Costantinos Bakogiannis, Christodoulos Stefanadis, 
1st Cardiology Department, University of Athens, Athens, Greece
Background: Marfan syndrome is characterised by high risk of aortic dissections and 
increased cardiovascular risk. However, the impact of Marfan syndrome on endothelial 
function and arterial stiffness is unclear, while the role of matrix metalloproteinases is 
unknown. We examined the impact of Marfan syndrome on the elastic properties of the 
arterial tree, and vascular endothelial function, and we evaluated the potential role of 
matrix metalloproteinases in these effects.
Methods: The study population consisted of 19 subjects with Marfan syndrome, aged 
26.3±2.1 years old, with BMI 20.3±1.0Kg/m2 and 22 healthy individuals matched 
for gender, age (26.4±0.78 years old, p=NS) and BMI (22.4±0.86 Kg/m2). Arterial 
stiffness was evaluated by measuring carotid-femoral pulse wave velocity (PWV), 
while augmentation pressure and augmentation index (AIx) were also determined, as 
measures of arterial wave reﬂections. Endothelial function was evaluated by determining 
ﬂow mediated dilation (FMD) in the brachial artery while matrix metalloproteinase 9 
(MMP-9) levels were determined by ELISA.
Results: Patients with Marfan syndrome had signiﬁcantly lower pulse pressure in the 
radial artery (40.0±0.9mmHg) compared to controls (51.3±4.4mmHg). In addition, patients 
had higher AIx (18.0±2.2%) and augmentation pressure (5.4±0.62mmHg) compared to 
controls (7.72±3.43% and 2.41±1.14mmHg respectively, p<0.05 for both). However, the 
difference in PWV between patients and controls did not reach statistical signiﬁcance 
(6.43±0.31 vs 5.96±0.23m/s respectively, p=NS). Patients with Marfan syndrome had 
lower FMD (2.15±1.10%) and higher plasma MMP-9 (830±68ng/ml) compared to controls 
(6.8±2.3% p<0.05 and 326±50ng/ml, p<0.01).
Conclusions: Marfan syndrome is associated with increased MMP-9 levels, as well as 
elevated augmentation index and augmentation pressure compared to healthy individuals. 
Moreover, ﬂow-mediated dilation is also impaired in these subjects. These ﬁndings 
suggest that Marfan syndrome directly affects the elastic properties and endothelial 
function of the arterial tree, with matrix metalloproteinases being important mediators in 
the pathophysiology of this syndrome.
9:30 a.m.
1053-218 Dilated Aortic Root in Adults With Repaired Tetralogy of 
Fallot: A Multicenter Prevalence Study
Craig S. Broberg, Jamil Aboulhosn, Francois-Pierre Mongeon, Deborah Gersony, 
George Lui, Joseph D. Kay, Michelle Nickolaus, Gary Webb, Paul Khairy, Stephen C. 
Cook, Anne Marie Valente, Alexander R. Opotowsky, Michael Landzberg, Michael G. 
Earing, Carole A. Warnes, Michelle Z. Gurvitz, Oregon Health and Science University, 
Portland, OR
Background: Although a predilection for ascending aortic root dilatation has been noted 
in repaired tetralogy of Fallot patients, little is known about its prevalence and associated 
factors.
Methods: Nine Adult Congenital Heart Disease centers measured aortic root diameters 
from echocardiograms in adults with repaired tetralogy of Fallot. Patients with prior aortic 
root/valve surgery were excluded. Ascending aortic distension and distensibility were 
calculated. Dilation was deﬁned as a root diameter q 40 mm. Groups were compared 
using t-test, chi-square, or non-parametric tests. Data are expressed as either mean ± SD 
or median [interquartile range].
Results: Of 464 patients screened, 8 had undergone prior aortic valve and/or root 
surgery and were excluded. Of the remaining patients, 379 patients had adequate 
echocardiograms for measurement (age 36 ± 12 years, 51% female). No patient had 
a history of aortic dissection. Root diameter averaged 34 ± 6 mm (range 21 - 61 mm). 
Abnormal dilation was present in 59/464 (25%), more likely in men (41% vs. 17% , 
p<0.001), and patients with pulmonary atresia (12/27 vs. 95/339, p=0.048). Patients with 
dilation were older (41±12 vs. 34±10 yrs, p<0.001), older at time of intracardiac repair 
(7[7] vs. 6[6] years, p<0.001), with a longer time between shunt placement and repair 
(6[49] vs. 4[40], p=0.028). Sixteen patients (4%) had q3+ aortic regurgitation, 50% of 
whom had a dilated root, a higher prevalence than patients with only mild (39%) or no 
(20%) regurgitation (p<0.001). Patients with dilation had a larger LV diastolic diameter (49 
± 7 vs. 43 ± 6 mm, p<0.001). Aortic root diameter was not signiﬁcantly different in patients 
with hypertension, which was not common in this cohort (N=9). Aortic area distention and 
distensibility were not different in patients with a dilated aortic root.
Conclusions: Dilated aortic root was found in 25% of adults with repaired tetralogy 
of Fallot, and associated with age, male gender, and older age at repair. Higher blood 
pressure or differences in aortic distention/distensibility were not found. No patients 
had prior aortic dissection. Further study of the etiology and signiﬁcance of aortic root 
dilatation is warranted.
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9:30 a.m.
1053-219 Low Rate of Complications After ICD Implant in Adults 
With Congenital Heart Disease
Amber D. Khanna, Sabrina D. Phillips, Peter A. Brady, Mayo Clinic, Rochester, MN
Background: Implantable cardioverter deﬁbrillators (ICD) are effective at terminating 
lethal ventricular arrhythmias and are increasingly employed in adult patients with 
congenital heart disease (CHD), yet implant complications and rates of appropriate and 
inappropriate ICD therapies are unknown.
Methods: We reviewed clinical, implant and follow-up data on all transvenous ICD 
implants in adults with CHD at Mayo Clinic between 1991 and 2008.
Results: A total of 73 patients (median age 40.6 years; range 19 to 70) in whom 86 ICDs 
were implanted during the study period were included. Implant diagnosis was Tetralogy of 
Fallot (43%), pulmonary stenosis/atresia (15%) and congenitally corrected transposition 
of the great arteries (14%). Implant indication was secondary prevention of ventricular 
arrhythmias in 59% and primary prevention in the remainder. Implant complications 
occurred in only three patients: atrial lead dislodgement, hypotension which responded to 
ﬂuid resuscitation, and elevated deﬁbrillation thresholds requiring a subcutaneous array. 
During follow up (mean 2.2 years; range 0 to 15) late complications occurred in 8% and 
included device recall for early battery failure, pocket infection after an atrial lead revision, 
three lead revisions due to dislodgement, and revision of an abdominally placed generator 
that migrated into the peritoneal cavity. In total, 19% of patients received an appropriate 
shock compared with 15% who received an inappropriate shock. Age, gender, ejection 
fraction, renal dysfunction, hemoglobin, implant indication and atrial lead placement were 
not associated with the occurrence of ICD shocks (appropriate or inappropriate). 
Conclusions: Implantation of a transvenous ICD in adults with CHD is associated with 
low risk of implant complications. In this high risk adult population the rate of inappropriate 
ICD shocks is low whereas the likelihood of appropriate therapy for potentially lethal 
ventricular arrhythmias is high. These data suggest overall beneﬁt of ICD therapy in adults 
with CHD.
9:30 a.m.
1053-220 Atrial Arrhythmias in Adults With Congenital Heart 
Disease: Right Versus Left Sided Lesions; Does it 
Matter?
Martin Bernier, Ariane J. Marelli, Judith Bouchardy, Natalie Bottega, Giuseppe Martucci, 
Louise Pilote, Judith Therrien, McGill University Health Centre, Montreal, QC, Canada
Background: Atrial arrhythmias (AA) contribute to the morbidity and mortality of adult 
patients with congenital heart disease (CHD).Whether right vs left heart lesions impact 
on the prevalence and outcome of AA is unknown. We compared the lifetime prevalence 
of AA in patients with right sided lesions (RSL) vs left sided lesions (LSL) and its impact 
on prognosis.
Methods: All patients q 18 yrs in 2005 were included. A CHD diagnosis was assigned to 
patient using ICD-9 diagnostic codes in administrative databases of Quebec, from 1983 
to 2005. Patients with AA were those diagnosed with an ICD-9 code for AA over the 18 
year study period. The cumulative lifetime risk of AA for RSL vs LSL was calculated. 
The hazard ratio (HR) for mortality, morbidity (stroke or heart failure), and interventions 
(cardiac cath, arrhythmia or cardiac surgery) were compared, after adjustment for age, 
sex and disease severity.
Results: Of 48 353 patients (R 24 684, L 23 669), 3954 developed AA (R 2 229, L 1725). 
Lifetime risk of developing AA was greater in patients with RSL compared to LSL (68.1 
% versus 61.8%, p < 0.001). This increased risk was especially marked in the younger 
patients and persisted over 3 decades of life. HR for mortality and development of stroke 
or heart failure were similar in both groups (0.96 (0.86 - 1.09), 0.94 (0.80-1.09) and 1.10 
(0.98-1.23), respectively) but rates of interventions were much greater on LSL (HR for 
cardiac cath 1.69 (1.47,1.95), cardiac surgery 2.63 (2.44-2.83) and arrhythmia surgery 
1.55 (1.18 - 2.03)).
Conclusions: Patients with RSL have a greater lifetime burden of AA. Their morbidity 
and mortality is no less than the LSL, yet intervention rate differs substantially. A better 
understanding of the mechanism of AA in patients with right sided lesions as well as 
a more aggressive approach towards the treatment of AA in these patients may be 
warranted.
9:30 a.m.
1053-228 Prospective Study of Cardiac Complications in 
Pregnant Women With Heart Disease
Candice K. Silversides, Jack M. Colman, Mathew Sermer, Rachel M. Wald, Jennifer 
Mason, Samuel C. Siu, University of Toronto Pregnancy and Heart Disease Research 
Program, Toronto, ON, Canada
Background: Identifying women at highest risk for adverse cardiac events (CE) during 
pregnancy is clinically important. Our group has previously published a risk score 
(CARPREG study) to identify women at increased risk. The objective of this study was to 
re-examine risk predictors in a large cohort of women.
Methods: This was a single center prospective study of consecutive women with heart 
disease undergoing pregnancy between 1994 and 2006. CE during the antenatal 
period and up to six months postpartum were recorded and included cardiac deaths, 
cardiac arrests, sustained or symptomatic arrhythmias, pulmonary edema and stroke. A 
multivariate logistic regression model was used to identify predictors of adverse events. 
In those women not previously reported (n=463), we evaluated the reproducibility of the 
CARPREG risk score.
Results: Of 797 pregnancies, 47 resulted in miscarriage or termination. Therefore, 
outcomes from 750 pregnancies (mean age 29 ± 6 years) in women with heart disease 
were examined. The most common diagnoses were congenital heart disease (n=463), 
rheumatic heart disease (n=103), arrhythmia disorders (n=74) and cardiomyopathies 
(n=49). Adverse CE occurred in 14% (103/750) of the pregnancies. The maternal cardiac 
mortality rate was 0.6% (5/750). Other CE included arrhythmias (59/750), pulmonary 
edema (48/750) and strokes (5/750) (events not mutually exclusive). Predictors of adverse 
CE during pregnancy included: baseline NYHA functional class or cyanosis (p<0.001), 
prior CE (p<0.001), signiﬁcant left-sided outﬂow obstruction (p=0.002), signiﬁcant 
systemic ventricular dysfunction (p=0.001) and the presence of a mechanical aortic or 
mitral valve (p=0.04). Using the CARPREG risk score, the frequency of adverse CE was 
7%, 18% and 46% in women with 0, 1 and >1 CARPREG scores. For women with 1 and > 
1 CARPREG predictors, the frequency of CE has decreased since our original report.
Conclusion: In this large contemporary series of women with heart disease, the risk 
of cardiac complications during pregnancy remains high. The CARPREG risk score 
continues to be predictive of events during pregnancy; however, the absolute risk for 
women is lower than previously reported.
9:30 a.m.
1053-229 Frequencies and Predictors of Cardiac Remodelling 
Post-Transcatheter Atrial Septal Defect Closure
Gerald Yong, Paul Khairy, Pierre de Guise, Annie Dore, Francois Marcotte, Lise-Andree 
Mercier, Reda Ibrahim, Montreal Heart Institute, Montreal, QC, Canada
Background: Closure of atrial septal defects (ASD) results in cardiac remodelling. We 
aim to evaluate the frequencies and predictors of resolution of dilated right ventricle 
(RV), dilated right atrium (RA), dilated left atrium (LA) and reduction of signiﬁcant (q2+)
tricuspid regurgitation (TR) after transcatheter ASD closure.
Methods: A cohort study was performed on 271 patients with successful transcatheter 
ASD closure.
Results: At 12 months post-procedure, ASD closure resulted in signiﬁcant reduction in 
the frequency of dilated RV, dilated RA, and signiﬁcant TR but not of dilated LA (see 
ﬁgure). Independent predictors of normalization of RV size among patients with dilated 
RV were lower baseline pulmonary artery systolic pressure (OR 0.965 per mmHg, 
p=0.0032) and longer time post-procedure (OR 1.001 per day, p=0.0002). Independent 
predictors of normalization of RA size among patients with dilated RA were lower baseline 
pulmonary artery systolic pressure (OR 0.953 per mmHg, p=0.0155), absence of atrial 
tachyarrhythmia (OR 0.146, p=0.0010) and longer time post-procedure (OR 1.001 per 
day, p=0.0229). Independent predictor of reduction in TR among patients with signiﬁcant 
TR was absence of atrial tachyarrhythmia (OR 0.078, p=0.0002).
Conclusion: Transcatheter ASD closure results in resolution of dilated RV, dilated RA 
and signiﬁcant TR but not dilated LA. Baseline pulmonary artery pressure and atrial 
tachyarrhythmia were signiﬁcant modulators of cardiac remodelling. 
